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Abstract 
Bacteria possess natural mechanisms allowing them to adapt to the environment 
and communicate with each other, processing large amounts of information in parallel. 
Cyanobacteria survive in a variety of environments and respond to light. Vibrio harveyi, 
a marine bacteria, and Pseudomonas aureofaciens, a wheat bacteria, communicate using 
small molecules; V. harveyi bioluminesces in response to an inter-species signaling 
molecule, while P. aureofaciens produces phenazine in response to its intra-species sig-
naling molecule. These inherent signaling mechanisms can be engineered to create rapid, 
specific, modular Bacteria-Based Molecular Assay Detection (B-MAD) systems. AB-
MAD system designed to detect the human pathogen Clostridium perfringens serves as 
proof of concept for completely biological information processing units. The B-MAD sys-
tem consists of three engineered cyanobacteria cells used in combination to detect Clos-
tridium perfringens, a causative agent in gas gangrene, food poisoning and antibiotic-
associated diarrhea. The B-MAD system is activated by blue/UV-A light and responds 
to AI-2, a small molecule produced by C. perfringens and perfringolysin 0, a C. perfrin-
gens pore-forming toxin. It is possible, using the yellow fluorescence and biolumines-
cence outputs from the B-MAD system, to unambiguously detect C. perfringens. The 
design of the B-MAD system as well as the fabrication of components for the Blue Light 
Converter are reported. 
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Introduction and Background 
Opening 
Bacteria naturally respond to changes in environmental factors, including tem-
perature, pH, and light. To protect themselves against changes which pose a danger to 
the bacteria, they posses the ability to move using flagella, sporulate in extreme condi-
tions (gram positive bacteria only) and translate proteins to protect themselves from 
harmful UV rays. Some bacteria release quorum sensing signals detectable by various 
other species of bacteria; these signals allow the individual bacteria to sense total bacte-
rial numbers present and trigger the production of virulence factors to help compete for 
resources in places with a large bacterial load. All of these methods are carefully con-
trolled by the bacteria, responding quickly to minute changes in the environment. The 
sensitivity, precision and capability to process and respond to a multitude of inputs si-
multaneously make bacteria extremely powerful and efficient data processors when 
compared to today's computer processing standards. Thus, researchers are beginning to 
explore the possibility of bacteria and their components as models for simple digital 
logic gates and parallel processors. While most of the current research evaluates the pos-
sibility of developing "DNA computers," there is the opportunity to use engineered bac-
teria themselves as sensors and computer processing components. 
In contrast to building computational systems within a single cell, few experi-
mental endeavors have focused on constructing computational networks involving mul-
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tiple cells. Some computer engineering groups have presented models and theory of in-
tercellular computational networks, but much of this research has yet to be carried out in 
the lab. Of the many researchers who have closely studied and characterized bacteria 
cellular communication, both intra-species and inter-species, these groups have focused 
primarily on the task of completely understanding and identifying all components in-
volved in the complicated biological signaling cascades. The information uncovered by 
these research groups serves as the backbone for developing engineered bacterial com-
municating networks. Such an intercellular network built through synthetic biology, en-
gineering the genetic elements of a cell to produce a specific, planned action in the re-
sulting cell, would have widespread applications. 
A biological intercellular computer has the potential to become a powerful new 
technology for researchers, industry and the military. Networks of cells completing 
computation and data analysis will allow scientists, doctors and engineers to tackle new, 
complex problems requiring unique, flexible computing capabilities. Biological comput-
ing networks could conceivably one day be used inside the human body to attack can-
cers, supply insulin, locate tumors and identify the difference between malignant and 
benign ones, monitor kidney function and detect infectious diseases. These biologically-
based computers will make it easier to interface traditional computing networks directly 
with biological molecules, such as insulin or botulinum toxin, without complicated, ex-
pensive traditional detection and computational equipment. This simple interface is par-
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ticularly useful in space-limited technology applications like those found on cruise 
ships, forward military hospitals or even on the space shuttle. The potential of develop-
ing biological computers is only now becoming apparent, as DNA tecnology provides 
researchers the power to freely alter the genes within a cell. While some have discussed 
the possibility of these biological computers, few have developed any type of purposely 
engineered intercellular network for practical clinical or industrial applications. 
Currently, few detectors exist for Clostridium perfringens. Today, more and more 
researchers are evaluating methods to detect C. perfringens due in large part to its po-
tential use as a bioterror agent. One patented detection method for Clostridium perfrin-
gens (pub. No. 20060028644, type Al) relies on the Raman light scattering of Clostridium 
perfringens for detection. This system also claims to be able to distinguish a wide variety 
of pathogenic microorganisms, including Bacillus anthracis, the Anthrax producing bac-
teria. Another commonly proposed detection method, although not fully defined, in-
cludes utilizing mixed PCR assays to identify microorganisms, specifically C. perfrin-
gens. The lack of a reliable, inexpensive Clostridium perfringens detector system led the 
U.S. government to fund "Project Zebra," where researchers work to develop a mecha-
nism to detect pathogens such as C. perfringens based on the gene response differences 
that occur in the presence of these pathogens. At this time, none of these C. perfringens 
detection systems are commercially used. 
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Traditional detectors for biological molecules rely on interfacing computers and 
other modern technology with biological systems. These systems work on the principles 
of the mechanical, chemical and electrical components of the specific artificial probe 
used in each application. By far, the greatest challenge for these sensing devices is inter-
facing with the biological systems. More modern detection systems, such as ELISA 
(Enzyme-Linked lmmunosorbent Assay) tests, where antibodies are used as detectors, 
incorporate a biological molecule to specifically detect a target molecule. These systems 
also have drawbacks; antibodies for these tests can be difficult to produce and take time 
to engineer, and the complexity of many infectious diseases make it difficult to identify 
specific etiologies with only one ELISA test. Rather, an array of tests together allow clini-
cians to diagnose many infectious diseases. Constructing a detection system that uses 
natural biological sensing mechanisms would allow the engineered bacteria to sense the 
environment, processing multiple signals, molecules and environmental conditions 
(light, pH, etc ... ) and make a determination of disease etiology based on the array of data 
collected by the bacterial system. Bacteria's ability to process data in parallel make a 
bacteria-based detection system advantageous in the clinic, as the bacterial system 
would perform the function of multiple traditional tests as well as the determination of 
etiology based on the data from the array of tests. The B-MAD system requires no elec-
trical power, as it is made up of cyanobacteria, which feed on light and nutrients in the 
environment. These systems have the potential to add specificity to the diagnosis of dis-
eases and streamline the diagnostic process, servings as unambiguous sensors rather 
than simple tests. 
15 
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Background -Natural Intercellular Signaling Systems 
For years, biologists have evaluated bacterial signaling mechanisms, both intra 
and inter-species. Perhaps the most well-known type of naturally occurring bacterial 
communication networks are "quorum sensing" systems, where bacteria send and re-
ceive signals indicating overall bacteria numbers. These signals can transcend species or 
be specific to only one species and have been identified in bacteria living in a wide vari-
ety of environments, from harmless marine bacteria to plant pathogens and even human 
pathogens such as Vibrio cholera. The intercellular communication of quorum sensing 
can be used to engineer networks of common bacteria. Two bacteria containing quorum 
sensing systems that are useful to designing engineered bacterial communication net-
works are Pseudomonas aureofaciens and Vibrio harveyi. 
One of the most well-studied quorum sensing systems occurs in Vibrio harveyi, 
an aerobic, gram-negative, marine bacterium. Vibrio harveyi is not a human pathogen, 
but its quorum sensing systems are analogous to those found in the human pathogen 
Vibrio cholera; the quorum sensing system in V. cholera controls virulence genes [l], 
while those in V. harveyi regulate bioluminescence. Therefore, researchers have worked 
to better understand the Vibrio quorum sensing systems in an effort to develop new 
treatments for cholera infections. Originally thought to have two parallel quorum sens-
ing systems, recent research has identified a third quorum sensing system in V. harveyi 
[2]. The quorum sensing systems in V. harveyi regulate a variety of genes, including bio-
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luminescence genes and are controlled by the quorum sensing signals HAI-1, AI-2 and 
CAI-1[2]. System one is regulated by HAI-1 and experimental evidence indicates that the 
signal is restricted to signal among V. harveyi [3]. System two is regulated by the small 
molecule, AI-2, which has the capability to stimulate a wide variety of bacteria, both 
gram-positive and gram-negative, and regulate an array of genes in the target bacteria 
[4]. Initial studies linked the production of AI-2 to the luxS gene. The luxS sequence was 
then used to query databases at the National Center for Biotechnology Information web-
site; there were 58 different bacteria identified containing the luxS gene [5]. As there are 
innumerable numbers of bacteria yet unidentified and un-sequenced, there will clearly 
be more bacteria identified that contain the luxS gene. As investigators evaluated the 
genes and functions controlled by luxS in the known bacteria, there was a link, although 
not universal, to virulence genes and toxins in some of the most common pathogens 
plaguing humanity. For example, bacteremic infection of Neisseria meningitidis was 
linked to regulation by luxS and AI-2 [6]. Cholera toxin production and toxin-
coregulated pilus are regulated by luxS and AI-2 in Vibrio cholera [7]. Secreted protease 
hemolysin in the common Streptococcus pyogenes infectious bacteria are controlled by 
luxS [8]. The alpha, kappa and theta toxins of Clostridium perfringens are also regulated 
by luxS and AI-2 [9]. In Campylobacter jejuni, a major food poisoning etiology, luxS was 
shown to control motility [10]. The specific functions, genes and mechanisms of AI-2 
control are still being uncovered. The examples listed above are only a small sampling of 
the widespread control that AI-2 has over bacteria. Clearly AI-2 and other similar signal-
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ing molecules play a major role in the pathogenesis of many bacteria. Careful analysis of 
the well-characterized quorum sensing signaling cascade regulated by AI-2 provides an 
opportunity to engineer the AI-2 signaling system to work to the advantage of research-
ers, clinicians and engineers. 
In general, there are two types of quorum sensing signals, one used most often 
by gram-negative bacteria and the other most commonly found in gram-positive bacte-
ria. Gram-positive bacteria, such as Staphylococcus aureus, utilize synthesized oligopep-
tides modified at specific locations and are detected by a response regulator protein that 
binds to DNA and regulates transcription[S]. Gram-negative bacteria, such as Vibrio 
harveyi or E. coli, most often synthesize acyl-homoserine lactone (AHL) autoinducers, 
which are able to freely diffuse across the bacteria cell membrane into the environment. 
These AHL's are detected by a specific class of proteins (LuxR-type), which in turn regu-
late gene transcription by binding specific DNA promoters [5]. AI-2, as well as the sys-
tem one autoinducer, HAI-1, and the more recently identified system three autoinducer, 
CAl-1, are AHLs. To be able to engineer these bacterial communication systems, specifi-
cally the AI-2 production and response system, it is crucial to understand their natural 
mechanism of action within the cell. 
Central to using AI-2 as an engineered signaling molecule is understanding the 
AI-2 production mechanism in V. harveyi and its production in a variety of other bacte-
rial species. The initial substrate for AI-2 is S-adenosylmethionine (SAM), and the proc-
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ess of synthesizing AI-2 relies on three enymatic steps [11]. In the synthesis of AI-2, SAM 
is converted to S-adenosylhomocysteine (SAH) when SAM is used in DNA synthesis, 
RNA synthesis or protein synthesis, which is a toxic intermediate that is hydrolyzed to 
S-ribosylhomocysteine (SRH) by S'methylthioadenosine/S-adenosylhomocysteine (Pfs), 
a nucleoside enzyme [11]. Then, luxS is the catalyst in cleaving SRH, forming 4,5-
dihydroxy 2,3-pentanedione (DPD), which cyclizes into furanone rings; one of those 
rings is the precursor to AI-2 [4]. AI-2's structure was eventually determined using crys-
tallography and shown to be a novel furanosyl borate diester [12]. As SAM is present in 
bacteria, as is Pfs, the addition of the luxS gene to bacteria would give it the potential to 
synthesize AI-2. 
In V. harveyi, AI-2 controls bioluminescence [13], Type III secretion systems (TTS) 
[14], polysaccharide [15] and metellaprotease [16] production. The AI-2 signaling cas-
cades consists of 5 major proteins, small regulatory RNAs and Hfq, an RNA chaperone 
[17]. LuxP, the trans-membrane AI-2 receptor, LuxQ an autophosphorolating protein, 
LuxU, a phosphotransferase protein, LuxO, a response regulatory protein, and LuxR, a 
transcriptional regulator, make up the AI-2 signaling cascade [2]. LuxR positively regu-
lates the luxCDABE promoter that activates the transcription of the bioluminescence 
gene. LuxR also negatively regulates the expression of TTS genes [14]. The main area of 
interest in the AI-2 signal cascade is the regulation of bioluminescence, as it will be use-
ful in engineering visual responses to AI-2 in cellular networks. In the absence of AI-2, 
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LuxP sits inactive across the inner cellular membrane, reaching into the periplasmic 
space. Meanwhile, with no active LuxP, LuxQ which phosphorolates LuxU and passes 
the phosphate to LuxO [18]. The phosphorolated and active LuxO activates small regula-
tory RNAs that work to destablize the luxR mRNA [2]. Experimental evidence indicates 
that LuxR is required for the transcription of the bioluminescence genes, so there is no 
bioluminescence without LuxR; therefore, with luxO active and inhibiting luxR mRNA, 
there is no bioluminescence [19]. Macroscopically, when LuxP is not bound to Al-2, the 
cascade inhibits bioluminescence. Conversely, when there is AI-2 bound to LuxP, luxQ 
acts as a phosphatase instead of a kinase, which ultimately removes the phosphate from 
luxO, rendering it inactive and unable to inhibit the expression of luxR [18]. Therefore, in 
the presence of AI-2, the signaling cascade permits the expression of LuxR and, subse-
quently, the expression of bioluminescent genes and control over other LuxR-regulated 
genes. Focusing on the bioluminescent respose of V. harveyi to the presence and absence 
of AI-2 demonstrates a simple biologically controlled signaling system incorporating 
both inputs and outputs. Experimentation has identified the bioluminescent response of 
V. harveyi to AI-2 and other autoinducers. Among the autoinducers, AI-2 has a distinct, 
strong response independent of the other two AHL signaling systems found in V. har-
veyi [20]. The AI-2 signaling cascade is a well-characterized and studied signaling sys-
tem to utilize in engineered cellular communication networks. 
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Pseudomonas aureofaciens strain 30-84, a gram-negative bacteria with the ability 
to suppress other bacterial disease of wheat, also has a characterized quorum-sensing 
system based on an AHL signal. The bacteria produces three phenazine antibiotics that 
suppress diseases of wheat [21] and similar to V. harveyi, has multiple identified inter-
cellular signaling systems. One of those two signaling systems, the PhzR-PhZI quorum 
sensing system, plays an integral role in the production and regulation of phenazine 
similar to the controlled expression of bioluminescence in V. harveyi [22]. Unlike V. har-
veyi, however, the PhzR-PhzI signaling system in P. aureofaciens is controlled through 
only a single responsive protein, PhzR, instead of a signaling cascade [23]. The AHL sig-
nal in P. aureofaciens is hexanoylhomoserine lactone (HHL or C-6-HSL), which, like 
other members of the AHL family of signals and autoinducers, freely diffuses across the 
cellular membrane. Once in the cell, C-6-HSL binds and activates PhzR, a transcriptional 
regulator of the PhzR operon that, in P. aureofaciens, controls the expression of phe-
nazine synthesis genes [22]. In the absence of the autoinducer C-6-HSL, PhzR is inactive 
and does not act as a transcriptional regulator. The autoinducer C-6-HSL is produced in 
P. aureofaciens via the expression of the phzI gene, which encodes an enzyme that cata-
lyzes the synthesis of C-6-HSL [22]. In contrast to the action of many AI-2 controlled 
functions, the function controlled by quorum sensing in P. aureofaciens has a protective 
effect for its natural habitat, wheat roots, displaying the wide variety of cellular proc-
esses that quorum sensing controls in bacteria. The PhzR-PhzI quorum sensing system 
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in P. aureofaciens provides a second, well-defined, signaling system to use and engineer 
in engineered bacterial communication networks. 
The AI-2 signaling system in V. harveyi and the C-6-HSL signaling system in P. 
aureofaciens are only two of the many currently identified quorum sensing systems 
identified. However, the vast majority of identified intraspecies and interspecies signal-
ing systems function through similar principles and similar AHLs. Research indicates 
that many of these systems are controlled by a similar class of "R" and "I" proteins 
(PhzR type and Phzl type) throughout the bacterial kingdom [23]. Many interspecies 
signaling systems also surely remain yet undiscovered. Understanding the diversity of 
signaling mechanisms and variety of functions and purposes of these systems is para-
mount when working to engineer nature's natural sensing systems to use them as sen-
sors, signals and other directed applications. 
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Background - Biological Information Processing Systems 
One research group that has begun exploring engineered cellular communica-
tions with some success is Weiss et. al. They developed and tested a simple two-cell 
model that was capable of receiving, processing and sending information between engi-
neered cells. The work, inspired by the bioluminescent quorum sensing system utilized 
by the marine bacterium Vibrio fisheri, uses the V. fisheri quorum sensing signal VAI 
messenger molecule as the informational unit [24]. The group modified E. coli DHS al-
pha cells to produce the signaling molecule VAI when in the presence of anhydro-
tetracycline (a Tc). They also developed a group of modified DHS alpha receiver cells that 
bioluminesce in response to VAL 
To demonstrate the communication between cells, Weiss et. al. first created a cell 
that would emit a signal molecule based on a known input, a Tc. The group accom-
plished this by controlling the expression of the luxl gene from V. fisheri, which is re-
quired for production of VAI, with a plasmid responsive to a Tc. Thus, when a Tc was pre-
sent, the luxl gene was expressed and it resulted in the production and release of VAI, a 
small molecule, from the cell. Weiss modeled this cell in terms of the AND digital logic 
gate, where a constitutively expressed inactive activator is activated through an inducer 
molecule and then expresses the luxl gene. Weiss et. al. model the bacterial system after 
digital logic gates used in computer engineering. 
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Digital logic gates represent the combination of transistors, diodes and resistors 
found in traditional electronic wiring diagrams and on modern circuit boards. The spe-
cific combination of these components creates one of five (5) of the most common digital 
logic gates: AND, OR, XOR, NOR and NAND. Each of these gates output one of two 
signals, either 1 or 0, depending on the input values. Individual gates have specific ar-
rays of conditions when the gate will output a 1 or 0. For example, an AND gate has two 
inputs and one output. If neither of the inputs is present, or either input is present alone, 
then the output is 0. Only when both inputs are present is the output of an AND gate 1. 
Weiss et. al. essentially built a biological AND gate that would respond to a single input 
(a Tc) because they engineered the second input as a constitutively expressed element 
within the cell. To create the AND gate corollary in the cell, Weiss et al. incorporated one 
of the required components in the production of VAI on a constitutive plasmid. Model-
ing these biological systems as digital logic gates is an important aspect of these bacterial 
combinatorial networks, as it allows mathematicians and computer scientists to model 
the systems and predict system response and suggest starting parameters for concentra-
tion and time when conducting experiments. 
Weiss et. al. also developed receiver cells made from E.coli DHS alpha [24]. 
These cells contained the LuxRPLPR operon from V. fisheri that is expressed in the pres-
ence of VAL Therefore, when VAI was present in the solution, the receiver cells would 
respond by expressing the LuxRP1PR genes and green fluorescent protein (GFP). When 
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these receiver cells were coupled with the sender cells (VAi producing, aTc-responsive) 
and aTc was added, the receiver cells would produce GFP and luminesce[24]. In this 
way, Weiss et. al. created the first engineered cell to cell communication network loosely 
based on the theory of digital logic gates. 
Another group, Thomas et al. from the University of California, Los Angeles 
(UCLA) also recently experimented with engineered cell to cell communication. Their 
experiments were based on manipulating the nitrogen regulation system and acetate 
pathway in E. coli to create an intercellular signal [25]. Thomas et al. also aims to utilize 
the power of quorum sensing between bacteria as a signaling system [26]. Acetate is 
used as the signaling molecule in these experiments, and the difference in pH across the 
membrane serves as the input signaling system. The receiver cells in this cell-cell com-
munication network respond with GFP, the same output signal used in experiments by 
Weiss et al.. As was the case with the Weiss experiments, Thomas et al.'s work was di-
rected largely by the prediction of a mathematical model. Through the model, the ex-
periment clearly demonstrated that varying pH cause varying fluorescence output [26]. 
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Background - Cyanobacteria 
Cyanobacteria have the distinction of being some of the oldest known organisms, 
with fossils dating back nearly 3.5 billion years. Originally classified as blue-green algae, 
they are actually gram-negative bacteria in the archae classification. Cyanobacteria are 
found all over the world. Cyanobacteria have played an important part in evolution, 
particularly in plants, where the chloroplasts are thought to be descendants of cyanobac-
teria that took up host in the cells and eventually became part of the cell through endo-
symbiosis. These bacteria, while primitive in origin, have appealing characteristics for 
use in engineered cellular networks; cyanobacteria naturally respond to light, require 
minimal nutrition for survival and survive at a wide variety of environmental conditions 
from hot-springs to cold ocean water. 
The light response of cyanobacteria is a useful characteristic to use in engineered 
systems [27]. Light can pose both a threat and benefit to cyanobacteria. On one hand, 
light is a source of energy for cyanobacteria, while too much light or high-energy wave-
lengths of light can be harmful. Research has identified specific photoreceptors that re-
spond to particular wavelengths of light such as red or UV light [28]. Various strains of 
cyanobacteria, including cyanobacteria strains Synechococcus elongatus PCC 7942 [29] 
and Synechocystis PCC 6803 [30] have identified photoreceptors and light responsive 
genes. 
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From a synthetic biology viewpoint, cyanobacteria Synechococcus elongatus 
PCC 7942 is an excellent light responsive bacteria to evaluate, as researchers have not 
only identified the light responsive genes, but already cloned the promoters for these 
genes. Additionally, a blue/UV-A light, responsive gene system has been characterized 
[31]. The blue light response network is based on high light inducible proteins (HLIPs). 
HLIPs are proteins that are proposed to serve in a protective manner against potentially 
damaging light rays by aiding the cell in handling reactive oxygen species. In the ex-
periments, blue or UV-A light was shown to stimulate transcription of the hliA gene [31]. 
Experiments demonstrated increased levels of transcription of the hliA gene in response 
to blue or UV-A light in times as short as 3 minutes [31]. Times shorter than 3 minutes 
were not investigated in the experimental models for response. Light induced signaling 
systems are targets for genetic engineering as they allow scientists to control engineered 
cellular activity via light, meaning that there is no actual contact between the engineered 
system and traditional electronic signaling equipment and no agents need to be added to 
the system. Previous studies have shown that some of light regulation in bacteria is post-
transcriptional [32], but transcriptionally controlled light response is more useful for 
cloning and engineering cells. 
Recently, the entire genome of cyanobacteria Synechocystis PCC 6803 has been 
sequenced. In fact, the genome for Synechocystis was the first cyanobacteria genome 
completely sequenced, making it the primary strain used for genetic studies in cyano-
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bacteria as well as photosynthetic bacteria in general [33]. Similar to PCC 7942, strain 
6803 has the ability to respond to light. Because the genome is sequenced in this strain, 
there has been ample research on incorporating foreign DNA into the chromosomal 
DNA of this strain as well as the production of a variety of plasmids that work well in 
cyanobacteria. Combined, the sequenced genome, the ability to survive at ambient tem-
peratures and the ease of transformation make cyanobacteria synechocystis PCC 6803 an 
excellent choice as a foundation cell for engineered bacterial cellular networks. 
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Background - Clostridium perfringens 
Clostridium perfringens is an anearobic, immobile, gram-positive spore-forming 
bacteria found naturally in the environment and the normal fecal flora of many indi-
viduals. There are five types of C. perfringens: Type A, B, C, D and E; the various types 
contain or express different toxins and are found in different environments. Few identi-
fied bacteria plague mankind in the variety of ways C. perfringens can. Part of the rea-
son for the wide array of illnesses C. perfringens causes is the large number of toxins 
produced by the bacteria, each of which affects cells differently; the three most common 
and studied toxins are alpha toxin, kappa toxin and theta toxin. Some of the diseases 
caused by C. perfringens range from mild gastroenteritis from food poisoning to multi-
ple organ failure, gas gangrene, necrotic enteritis, and antibiotic associated diarrhea. In 
fact, with 250,000 cases per year in the United States, C. perfringens is the third leading 
cause of foodbourne illness in our country [34]. There currently are few ways to rapidly 
identify the presence of C. perfringens in a wound or as the etiology in a food poisoning 
outbreak because, as an anaerobe, it is difficult and time consuming to culture and does 
not readily survive in air. Rather, most clinicians, especially in cases of potential gas 
gangrene, rely on clinical presentation, sound and smell to make a diagnosis. Depending 
on the disease, treatment options for C. perfringens are limited and often must be ad-
ministered early after infection. Some of these treatments are unique and even include 
the use of hyperbaric oxygen therapy [35]. While C. perfringens is most often thought of 
as a threat to immuno-compromised people, its potential to inflict mortality, economic 
hardship from medical costs and danger to armed forces personnel as food poisoning 
stands to potentially immobilize entire platoons of military personnel make C. perfrin-
gens a bacteria of interest to infectious disease researchers. 
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Gas gangrene, the most traumatic, visual and potentially fatal disease caused by 
C. perfringens, occurs when exposed wounds are infected with C. perfringens through 
unintentional exposure to environmental sources or even self-contamination through 
fecal and body samples. Gas gangrene infections have plagued humanity as far back as 
medical records exist, even though the etiology was not initially identified until 1892. 
They began to gain notoriety during the first World War, when large numbers of 
wounded soldiers succumbed to the fast acting disease [36]. Originally dubbed "gas 
edema," "mignant emphasema," "gas inflammation," and "gas phlegmon," gas gan-
grene was a major obstacle to World War I physicians because clinical diagnosis was dif-
ficult and unreliable and fulminant gas gangrene progressed rapidly [36]. Clinicians at 
the time who were able to feel gas pockets in the wound, tap the wound and hear a 
tympani-like percussion roll or see gas bubbling from an open wound were able to suc-
cessfully diagnose a gas gangrene infection [36]; this detection method is still often em-
ployed today. 
The gas gangrene infection itself manifests by myonecrosis, destruction of local 
muscle tissue, necrosis of other tissues in the area and shock [37]. Of all the identified C. 
perfringens toxins, alpha toxin (phospholipase C) and theta toxin (perfringolysin O) are 
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the two major toxins involved in the progression of gas gangrene [38). Experimental evi-
dence demonstrates that both phospholipase C (PLC) and perfringolysin O (PFO) are 
required for a gas gangrene infection to persists in the tissue [39). PFO has been shown 
to perforate 20-30nm pores in cholesterol containing membranes [40), whereas PLC in-
duces hemolysis via a series of different signaling cascades within the cell [41). Unless 
treated very early with antibiotics, most often penicillin, or unless infected tissue is 
completed removed, gas gangrene can progress to mortality within 6 hours. 
Fortunately, gas gangrene infections are relatively rare. Most cases occur in mili-
tary field wounds, hiking accidents or climbing accidents, when the time to reach suffi-
cient medical care and have wounds cleaned is long, thus allowing any C. perfringens 
spores that enter the open wound the opportunity to begin growing. Another common 
gas gangrene occurrence is in bum victims, where there is a lot of damaged and exposed 
tissue and generally a suppressed immune system. Sometimes, however, gas gangrene 
occurs in rare instances, even among healthy people with fatal consequences, further 
demonstrating the need for better detection mechanisms. One example is a case where a 
57 year old live liver donor successfully underwent the donation without complication 
[42). The following evening, the patient had a lobster dinner, and within 24 hours expe-
rienced nausea, altered mental capacity, tachycardia, which eventually led to cardiac ar-
rest and death. The autopsy showed that a type of C. perfringens, Type D, which boasts 
another systemic toxin, epsilon toxin, cause gas gangrene in the stomach and eventually 
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led to mortality; the C. perfringens came from the lobster dinner [42]. Curing these 
types of C. perfringens infections is only effective at the very early stages and even then 
is only marginally effective. Undoubtedly, rapid detection is a must for a positive out-
come. 
The other major component of C. perfringens infections targets the intestines and 
results in varying levels and types of gastroenteritis and diarrhea. Often in cases of intes-
tinal disease, it is difficult to determine if the infection initiated from something that was 
ingested or if it was a flare-up of C. perfringens in the microbial flora of the intestines, as 
30% of the population are naturally colonized with C. perfringens [42]. While most of 
the time these infections are far less severe than gas gangrene, they comprise the vast 
majority of C. perfringens infections .. These intestinal infections range from simple, mild 
gastroenteritis, to the common antibiotic associated diarrhea, necrotizing colitis and the 
rare disease, Pigbel. The target and action of C. perfringens varies in each type of infec-
tion. In antibiotic associated diarrhea, patients administered antibiotics have their natu-
ral intestinal microbial disrupted. C. perfringens then colonizes the intestines and the 
toxins cause diarrhea. The other intestinal infections vary in severity and specificity, with 
all types of people infected. One interesting case of an outbreak of C. perfringens at a 
mental facility following a Thanksgiving meal resulted in 2 deaths, of 7 cases of entero-
toxigenic C. perfringens and 3 cases of acute necrotizing colitis [34]. The effects of food-
borne outbreaks of C. perfringens and subsequent infections, while not always life 
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threatening, carry the economic burden of missed work hours and wages and associated 
medical costs for tracking the source and treating infected patients. The missed work 
hours pose an especially dire situation for military personnel. 
Studies of C. perfringens and its associated disease states have been studied out-
side of humans as well. As an example, an outbreak of necrotizing enteritis linked to C. 
perfringens plauqed a Korean ostritch farm in 2000 and brought significant economic 
hardship on the farmers because of the loss of livestock [43]. Other research groups have 
evaluated C. perfringens growth and persistence in food. For example, one study by the 
Dutch Inspectorate for Health Protection and Veterinary Public Health in 2001 demon-
strated the presence of C. perfringens in canned soup [44]. Additional rapid testing tech-
niques to identify C. perfringens in food prior to consumption or distribution could re-
sult in decreased infections and a better economic outlook for farmers, food packagers 
and potentially ruined restaurant chains over poor publicity following inadvertent out-
breaks. 
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B-Mad System 
Introduction to 8-Mad System 
The Bacterial-based Molecular Assay Detection System [B-MAD System] for C. 
perfringens is designed for both military and civilian applications. It is an engineered 
network of bacterial cells designed to detect C. perfringens. The portability, compact 
size, minimal nutritional requirements and rapid response of the B-MAD system is ideal 
for the military. The system will allow military personnel aboard vessels and forward 
bases to test foodstuffs for potential food poisoning, identify C. perfringens infections 
quickly in combat wounds, even during transportation to the nearest trauma unit, and 
track and contain the sources of C. perfringens food poisoning outbreaks. Additionally, 
the B-MAD System is a useful diagnostic tool for clinicians at hospitals and rural medi-
cal clinics. It provides an epidemiological tool for researchers at public health depart-
ments tracking and identify food poisoning etiologies. Farm operators could also look to 
the B-MAD system as a method to contain C. perfringens outbreaks in swine, ostrich or 
other livestock. 
Harnessing cyanobacteria' s minimal nutritional requirements, self-
reproducibility and natural capability to respond to environmental stimuli and commu-
nicate, it is possible to develop new, modular, detection systems based solely on engi-
neered bacteria for detecting infectious diseases, toxins and small molecules. The natural 
sensitivity and specificity of biomolecular systems, combined with intercellular commu-
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nication among bacteria, allows for detection of target molecules; a unique biologically-
based reporter system provides a user interface to the system. An initial application of 
the Bacterial-based Molecular Assay Detection System [B-MAD System], chosen as a 
proof of concept, is the detection of C. perfringens in wound swabs, fecal samples, and 
food. 
The B-MAD System uses bioluminescence and biofluorescence as outputs. The 
genetic elements making up the B-MAD System are cloned from naturally occurring bac-
teria communication and sensing systems. Cyanobacteria make up the backbone of the 
B-MAD System, and since cyanobacteria readily survive at room temperature for ex-
tended periods of time, the B-MAD System will be extremely portable. The B-MAD Sys-
tem is flexible and designed to have interchangeable and customizable components to 
serve as a detection or relay system for numerous toxins or bacteria. Each application of 
the B-MAD System detects extra-cellular molecules specific to the target bacteria. 
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B-MAD System Design 
The B-MAD sensing system is a modular, completely biological device consisting 
of a network of engineered bacteria containing an "on/ off" switching module and two 
combined "sensing" and "processing" modules. The B-MAD system responds to three 
separate inputs: 1) blue/UV-Alight as a 
"start-up" signal, 2) perfringolysin 0 
(PFO), a C. perfringens toxin, and 3) AI-2, 
an extra-cellular molecule produced by C. 
perfringens. When combined, these three 
inputs result in the detection of C. perfrin-
gens in a sample (see Figure 1). 
The B-MAD system has three bacte-
ria cell types that serve as the "processor" 
of the system. Cyanobacteria were chosen 
as processing cells, as they grow, live and 
remain alive for extended periods of time 
without specific maintenance at ambient 
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Figure 1: Illustration of B-MAD System re-
sponse to stimuli (UV light & signaling mole-
cules) . 
room temperature. As well as being robust, cyanobacteria naturally respond to various 
wavelengths of light in different ways, an important characteristic for the system be-
cause the molecular systems necessary for light responsiveness are intrinsic to the bacte-
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ria. Cyanobacteria strains 7942 and 6803 serve as host cells; genetic engineering of these 
strains will create the B-MAD system. Strain PCC 7942 is the host cell for the blue light 
converter or system activator. The other strain, 6803, serves as the host cell for the two 
combinatorial processor cells. The system itself is divided into three separate cell com-
ponents: a Blue Light Converter cell type (BLC), an Al-2 / C-6-HSL Computational cell 
type (ACC) and a C-6-HSLPFO Computational cell type (CPC). These three cell types, 
combined in a modular fashion, provide the detection of C. perfringens presence. 
Prior to use, the B-MAD system is inactive, contained 
in a microcentrifuge tube, cuvette or other small container 
useable in portable fluorimeters and luminometers (see Fig-
ure 2) . The blue / UV-A light activates the system through the 
Blue Light Converter cell prior to exposure to potentially 
infected fluids, tissue swabs or fecal material. Upon activa-
tion, the system will fluoresce yellow, which serves as an 
"on" indicator. The positive signal indicates to users that the 
system is both active and working; it also provides a base-
Figure 2: B_MAD system 
sketch illustrating three cell 
types in potential system 
packaging. 
line system fluorescence level. After activation, the system is exposed to the potentially 
infected material. If there is AI-2 present, the system will bioluminescence (produce a 
blue-green light) via the ACC cell, which detects C-6-HSL and AI-2. If there is PFO pre-
sent, there will be a change in yellow fluorescence (either a distinct dimming or increase 
in brightness, depending on system 
preliminary test results) from the 
CPC cell, which detects C-6-HSL and 
PFO. A change in yellow fluores-
cence, combined with biolumines-
cence, indicate C. perfringens pres-
ence. Bioluminescence and a change 
in yellow fluorescence provide an 
unambiguous system output. 
Each of the two processor 
cell types (ACC cell and CPC cell) 
detects the activation signal, blue/ 
UV-A light, and one of the signaling 
molecules. Thus, the two processor 
cells, together, determine if there is 
C. perfringens in the sample when 
both are activated and each senses 
bioluminescence 
alone= 
no 
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no 
change= 
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Figure 3: Illustration of B-MAD system in use and 
possible system outputs. 
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one of the signaling molecules (i.e.: respond indicating Al-2/ C-6-HSL positive and PF0 
C-6-HSL positive. See Figure 3). The B-MAD system is able to use the combination of 
inputs to separate the detection of C. perfringens from other bacterial, fungal, toxin or 
viral infections, as PFO 
and AI-2 production to-
gether is unique to C. 
perfringens. Addition-
ally, other bacteria that 
may produce AI-2, PFO 
or similar molecules to 
PFO or AI-2 would not 
inhabit the same envi-
ronment. Therefore, the 
B-MAD system is able to 
detect C. perfringens 
relying solely on bacte-
rial sensing mechanisms. 
The B-MAD sys-
tern is an analogue to 
digital logic AND gates, 
which are digital signal 
processing units that re-
ceive two inputs and 
C-6-HSL 
no 
yes 
no 
yes 
C-6-HSL 
no 
yes 
no 
yes 
Biolum. 
no 
yes 
no 
yes 
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AND Gate "1" from figure 
AI-2 Biolum. 
no no 
no no 
yes no 
yes yes 
AND Gate "2" from figure 
PFO ti in fluor. 
no no 
no no 
yes no 
yes yes 
AND Gate "3" from figure 
ti in fluor. C. perf. 
no no 
no no 
yes no 
yes yes 
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provide a single output; if both inputs are positive, the AND gate signals a 1, or positive 
output, while in all other 
Digital Signal Processing AND Gate 
cases it signals a zero, or 
negative output. As 
shown in the figure on 
the right, both the ACC 
and CPC processing cells 
are analogous to digital 
Input 1 
0 
1 
0 
1 
logic AND gates. Additionally, the change in yel-
low fluorescence and bioluminescence work to-
gether as a digital logic AND gate. Globally, the 
entire B-MAD system can be viewed as a digital 
logic AND gate, with PFO and AI-2 serving as the 
inputs giving a positive or negative output de-
termining whether or not there was C. perfrin-
gens present. The following tables correspond to 
Input 2 Output 
0 0 
0 0 
1 0 
1 1 
B-MAD Digital Logic 
Gate Analogue 
I 
\ 
Al-2 
I 
\ 
' 
' 
V - fluor. 
✓ 
✓ 
I 
I 
I 
I 
',, ____ !----~,,' 4 
C. Perfringens 
+ or -
Figure 4: B-MAD Analogue 
the digital logic AND 
gates in the ,schematic. 
These tables demon-
strate the relationship 
between the AND gate 
used in digital signal 
processing and the 
AND gate analogues in 
the B-MAD system. 
AND Gate "4" from figure: Global B-MAD AND Gate 
AI-2 PFO C. per£. 
no no no 
yes no no 
no yes no 
yes yes yes 
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Blue Light Converter Cells (BLC) 
The following section is a design and construction plan for the Blue Light Con-
verter cell. The section includes a detailed design of the BLC cell, including all required 
components and their role in creating the BLC cell. An experimental construction plan is 
included laying out the steps and specific cloning required to construct the BLC. 
The Blue Light Converter, engineered cyanobacteria PCC 7942, is the B-MAD 
system activator, providing visual feedback that the system is viable and functioning 
while also prepping the other processing cells for detection. In response to UV-A/B 
light, the BLC cells produce and secrete C-6-HSL, a small intercellular signaling mole-
cule normally found in Pseudomonas aureofaciens. This molecule serves as the activat-
ing signal for both computational cells. 
UV-A/B Light 
' 
0 
C-6-HSL 
0 •Cv f Phzl protein _phzlgene 
')liA promoter 
'o 
C-6-HSL 
Figure 4: Illustration of the Blue Light Converter cell (engineered cyanobacte-
ria 7942), components and response to Blue or UV light. 
Cyanobacteria strain PCC 7942 reacts to UV-A/Blight by upregulating the hliA 
genes. In nature, these genes produce molecules that protect the bacteria from the harm-
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ful effect UV light has on cellular components. Coupling the hliA promoter to the phzl 
gene on a plasmid within cyanobacteria PCC 7942 creates the Blue Light Converter. The 
BLC harnesses this intrinsic response to UV light stimulation by utilizing the hliA pro-
moter to induce transcription of the gene coding for the precursor substrate to the C-6-
HSL molecule, phzl, in response to UV light. Using this newly engineered cell, it will be 
possible to create C-6-HSL in response to UV light. The C-6-HSL molecule interacts with 
the the 1st computationaldetector cell (CPC), causing transcription and translation of 
yellow fluorescent protein (YFP) via C-6-HSL dependent YFP 
transcription. In the second computationaldetector cell (ACC), C-
6-HSL induces the transcription and translation of luxP, the AI-2 
receptor. 
A staged construction is planned to construct the Blue 
Light Converter, consisting of two major steps: cloning and trans-
formation. To create the BLC, the hliA promoter will be cloned 
Creale hfA & phzl 
plasmid 
Transfect Cyanobadeda 
7942 
Test Blue light- phzJ 
producfion 
Figure 5: Construction 
flowchart for BLC cell. 
into a plasmid for cyanobacteria. Then, cloning the phzl gene into the cyanobacteria 
plasmid adjacent to the hliA promoter creates the final plasmid. After transformation of 
the cyanobacteria, exposure to Blue or UV-A light and successful assay to determine C-6-
HSL production, the BLC is complete. 
(::_---■I---. 
pBhliA 
1 
c:::---■■ 
pBhliA • 
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• • 
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/4gestion 
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C-6-HSL Blue Light Converter 
Figure 6: Construction outline for the BLC converter cell, including all intermediate 
plasmids required for construction of the BLC. 
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C-6-HSLPFO Computational Cell (CPC) 
The following section is a design and construction plan for the C-6-HSLPFO 
Computational (CPC) cell. The section includes a detailed design of the CPC cell, includ-
ing all required components and their role in creating the CPC cell. An experimental 
construction plan is included laying out the steps and specific cloning required to con-
struct the CPC cell. 
The C-6-HSLPFO Computational cell (CPC) demonstrates system activation with 
the production of yellow fluorescent protein (YFP), which is also required for detection 
of the C. perfringens toxin perfringolysin O (PFO). PFO interacts with cholesterol in the 
plasma membrane of eukaryotic cells to form pores, which causes the cellular contents 
to spill out into the extra-cellular space, killing the cells. PFO will be detected through a 
similar mechanism in the B-MAD system. In the presence of PFO, CPCs will form pores 
and die, resulting in YFP diffusing into the extra-cellular space, affecting the fluores-
cence signal. There are two potential fluorescent signals visualized once the YFP escapes 
the cells. In either case, the change in fluorescence registered by the system will count as 
a PFO presence. When the YFP escapes the cells through pores formed by PFO, either 
the YFP intensity registered will decrease because it is now less concentrated within the 
cell or the overall YFP signal may increase because of interactions with extra-cellular 
molecules present. Testing of the CPC cell will allow for calibration in either case. With 
the production of YFP and interaction with PFO, the CPC cell serves not only as a detec-
tor of PFO, but also as a bioassay 
for PFO activity. 
In nature, Pseudomonas 
aureofaciens, a plant pathogen, 
employs a quorum sensing sys-
tern to detect bacterial numbers. 
This quorum sensing sensing de-
tection system responds to the 
presence of a small molecule, C-
6-HSL. This small molecule inter-
acts with PhzR, a transcriptional 
activator for the phzE promoter 
(see Figure 7, #1) . 
Using the C-6-HSL re-
sponse network from P. aureofa-
ciens, the PhzR protein and its 
target gene promoter phzE, YFP 
0 
C-6-HSL 
0 
C-6-HSL 
CPC Cell Detail 
Cholesterol 
I. Activation With C-6-HSL 
~ .. 
O +b 
C-6-HSL PhzR 
2. PFO Present 
C-6-HSL/PFO Computation Cell 
(Host: Cyanobacteria Strain 6803) 
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Figure 7: Illustration of CPC Cell and mechanism of action 
production occurs when C-6-HSL is present in the extra-cellular fluid. The C-6-HSL 
molecules diffuse across both cell membranes, bind to the PhzR protein in the cytosol 
and directly promote the transcription of the gene attached to the phzE promoter, in this 
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case YFP (in the engineered construct). In the B-MAD, C-6-HSL is derived from the BLC. 
Thus, light activation of the BLC leads to C-6-HSL production, leading to "activation" of 
the CPC cell, causing it to fluoresce yellow (see Figure 7, #2). These components will be 
added to the chromosome of the cyanobacteria 6803 host. Addition of DNA to the chro-
mosome in the cyanobacteria is simple, which is one of the reasons it was chosen as a 
host. Chromosomal DNA is more stable than plasmid DNA, which should help to stabi-
lize the entire B-MAD system. 
In eukaryotes, PFO binds cholesterol in the cellular membrane and forms large 
pores, exposing the cytoplasm to the environment and resulting in cell death. Cyanobac-
teria 6803 do not normally contain cholesterol in its membranes. Therefore, we will have 
to engineer them to contain cholesterol. Some prokaryotes, particularly obligate intracel-
lular pathogens like Ehrlicia and Chlamydia, incorporate cholesterol from the host cell 
into their membranes to provide additional support and stability for the cell wall. The 
concept is to stimulate the cyanobacteria cells to incorporate the cholesterol into the 
membrane. A second solution, if there is difficulty stimulating the cyanobacteria to in-
corporate cholesterol into the membrane, involves adding the necessary processing 
genes required to form cholesterol naturally in the cyanobacteria host cell, strain 6803. A 
third option includes the potential use of ergosterol, a structurally similar molecule to 
cholesterol found in parasites; the PFO may also work against ergosterol. Once the cho-
lesterol is added, perfringolysin O toxin will be directly added to the solution to deter-
mine the effects on the modified cyanobacteria cells; these tests will indicate time re-
quired for toxin action and amount of toxin required to elicit the desired response. 
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To develop the CPC cell, the C-6-HSL receptor proteins and responsive genetic 
units, including the YFP gene, must be incorporated into the cell, which must then have 
its membrane cholesterolized (see Figure 8). Cholesterolizing the membrane and devel-
oping an C-6-HSL strain can be 
completed in parallel. Focusing on 
the addition of cholesterol to the 
membrane, there is a chance that 
(1J 
Cteale phzE:YFP DNA 
Transfed Cyanobacleda 
6803 Chromosome: create 6803 
C6YFPceR 
TeatYFP 
Produc:tion 
(2J 
TestPFO 
Response 
the cyanobacteria cell membranes 
will naturally take up cholesterol 
into their membrane. Other poten-
(3J I c~ ---I --~•I..., ...... Tu_response_Y1'_P._'IP_FO_.,. 
tial solutions involve incorporating Figure 8: Task list and flow chart for construction of CPC 
cell. 
ergosterol into the membrane or 
cloning the genetic machinery required to allow the cyanobacterial 6803 to produce cho-
lesterol for the membrane. The hope is that experimentation can show cyanobacteria 
6803 will uptake cholesterol without significant engineering. 
Meanwhile, cloning approach will produce the phzE:YFP cyanobacteria DNA 
and constitutively expressed DNA for phzR, the C-6-HSL receptor. PhzR protein, since it 
is required for the reception of and successful response to C-6-HSL, must be present in 
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the cell. To achieve this, a constitutive cyanobacteria promoter can be linked to the phzR 
gene, ensuring transcription and expression of the phzR gene in cyanobacteria and, thus, 
the phzR protein. The promoter for the phzE gene, target of PhzR and controlling the 
YFP expression, will be linked via restriction enzymes to the YFP gene. Because of the 
nature of cyanobacteria 6803, the cyanobacteria will be transfected (adding the DNA to 
the chromosome instead of transforming with a plasmid) so that the phzE promoter: 
YFP construct and the constitutive promoter: phzR gene integrate into the cyanobacteria 
chromosome, providing a more stable engineered cell. 
The created strain of cyanobacteria 6803 containing the CPC genetic elements can 
then be treated and engineered as required to incorporate cholesterol through methods 
explored on wild-type cyanobacteria 6803. See Figure 9, 10 and 11 for detailed construc-
tion diagrams. 
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Figure 9: Construction outline for adding C-6-HSL responsive components in the CPC 
cell. 
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Cholesterol 
Cyanobacteria 6803 
membrane cholesterolization 
Cyanobacteria 6803 w/ cholesterol 
Figure 10: Construction outline for PFO toxin response in the CPC cell: addition of cholesterol 
to cyanobacteria 6803 membrane 
j 
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Figure 11 : Construction outline for completion of CPC cell. The C-6-HSL responsive cell is choles-
terolized to form the CPC cell. 
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AI-2/C-6-HSL Computational Cells (ACC Cells) 
The following section is a design and construction plan for the Al-2/C-6-HSL 
Computational (ACC) cell. The section includes a detailed design of the ACC cell, in-
cluding all required components and their role in creating the ACC cell. An experimental 
construction plan is included laying out the steps and specific cloning required to con-
struct the ACC cell. 
The AI-2/C-6-HSL Computational (ACC) cell detects the presence of AI-2, a 
small, non-toxic molecular product of C. perfringens. Initially described in the marine 
bacterium, Vibrio harveyi, AI-2 can be found in over 30 different bacteria species from E. 
coli to V. cholera (but not cyanobacteria). The identification of AI-2 alone in the media 
does not definitively indicate a C. perfringens infection, but when coupled with the CPC 
cell that senses the C. perfringens toxin perfringolysin 0, a definitive diagnosis is possi-
ble; no other known bacteria produces this combination of products. 
The ACC cell is "activated" by the C-6-HSL produced by the BLC cells following 
priming with UV-A/Blight. When C-6-HSL is present, the ACC cell produces the recep-
tor for AI-2, now making the ACC cell responsive to AI-2 and able to bioluminesce. 
Without the AI-2 receptor, the ACC cell is unresponsive to AI-2 in the media; thus, with 
AI-2 or C-6-HSL alone, there would be no bioluminescence; bioluminescence is only 
possible when both C-6-HSL and AI-2 are present or when AI-2 is present and the cells 
have already been primed with C-6-HSL.. To achieve this goal, biochemical sensing sys-
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terns from Pseudomonas aureofaciens and Vibrio harveyi are introduced into cyanobac-
teria strain 6803. 
As discussed for the CPC cell, Pseudomonas aureofaciens, a plant pathogen, em-
ploys a quorum sensing system to detect bacteria numbers. This quorum sensing system 
detection system responds to the presence of a small molecule, C-6-HSL. This small 
molecule interacts with PhzR, a transcriptional activator for the PhzE promoter. In P. 
aureofaciens, the phzE gene codes for the phenazine biosynthesis protein. 
The marine bacteria Vibrio harveyi possesses a well-documented AI-2 sensing 
system. The backbone of the AI-2 detection system consists of four separate proteins: 
LuxP, LuxU, LuxO and LuxR. LuxP is the trans-membrane receptor for AI-2. In the AI-2 
signaling pathway, AI-2 in the extracellular fluid crosses the outer cell membrane of the 
gram-negative V. harveyi and binds to the LuxP protein stretching into the periplasm 
outside the inner cell membrane. LuxQ now swtiches from a kinase to a phosphatase 
[11], and the phosphate is removed from LuxO; LuxO is inactive when unphosphory-
lated and cannot promote transcription of small regulatory RNA's (sRNA) that destabi-
lize luxR mRNA [2]. Thus, LuxR is trans-
lated and induces bioluminescence by 
promoting luxCDABE transcription, the 
bioluminescence genes, allowing V. harveyi 
to naturally bioluminesce in response to AI-
2. 
The ACC cells take advantage of 
both the Pseudomonas and Vibrio sensing 
pathways to detect AI-2. In the engineered 
ACC cyanbacteria cell (see Figure 12), C-6-
HSL diffuses through the outer membranes 
where it interacts with PhzR, a P. aureofaci-
ens protein. C-6-HSL binds to PhzR, a tran-
scription factor, leading to the transcription 
of the luxP gene via the phzE promoter, a 
phzR responsive element. The luxP genes 
driven by the pzE promoter code for the 
luxP protein, the "reporter" in the V. harveyi 
AI-2 signaling pathway. Without LuxP, the 
ACC cell in incapable of bioluminescence in 
0 
C-6-HSL 
0 
C-6-HSL 
0 
C-6-HSL 
f ,-. ------+ LuxPQ ~phzE promoter 
LuxN 
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LuxO 
J 
1. Activation With C-6-HSL 
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c-f2st~R / 
LuxO 
J 
2. No Al-2 Present 
f ,-. ~phzE promoter 
C-Qst~R / 
LuxO 
' ' ' I / /.,, 
--Bioluminescence-
3. Al-2 Present 
Figure 12: Illustration of AI-2 layout and 
mechanism of action. 
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response to AI-2. Additionally, LuxQ provides the necessary autophosphorylation of 
LuxO to ensure that expression 
of luxR is inhibited unless AI-2 is 
present and bound to LuxP. 
There are a multitude of 
genes and promoters required to 
complete the ACC cell, and a 
clear construction plan is re-
quired to ensure all elements are 
(3.) 
<1.) 
Ttlllldlr:t ~ 6803 
AACC Chromosome 'Ill 
/uJtPQ:phzE DNA: Cresfe 
ACCCe/1 
Clone 
IUllCOABE 
(2.) 
Trln/lll'ed ~ 
6803 AACC: CRlllle 6803 
AACCTcell 
TestAJ-2/C6-HSL 
lJioluminescem; 
lqDJSe 
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properly added (see Figure 13). 
To simplify the construction of 
the ACC cell, the two receptor 
pathways and response systems, 
C-6-HSL and AI-2, will initially 
Figure 13: Construction flowchart for ACC cell. The flow-
chart illustrates a design mechanism for the ACC cell. 
be cloned into separate cells to 
verify each system independently prior to combination of both systems in the final ACC 
cyanobacteria 6803 cell. 
In the C-6-HSL response component ACC precursor cell, DNA coding for the 
luxP gene must first be linked to the phzE promoter. Additionally, the phzR gene must 
be linked to a cyanobacteria constitutive promoter. Then, both of these elements, inde-
57 
pendently, may be added to cyanobacteria 6803 chromosomal DNA via transfection. Us-
ing this stable test cell, it is possible to tag the luxP protein with a 6 histidine tag to be 
used as a verification of response to C-6-HSL assay. 
In the AI-2 response component ACC precursor cell, multiple DNA components 
must be cloned, linked and transfected into the cyanobacteria 6803 chromosomal DNA. 
The luxCDABE operon from V. harveyi and associated promoter region must be cloned 
and then added to the cyanobacteria. Similarly, the luxR gene must be cloned and incor-
porated into the cyanobacteria. Next, luxQ luxU and luxO must all be linked to a cya-
nobacteria constitutive promoter and then added to the cyanobacteria chromosomal 
DNA. After verifying the successful addition of each of these components, preferably 
through sequence analysis, the ACC precursor cell must be tested for AI-2 response vi-
ability. However, the AI-2 receptor, LuxP, is not incorporated into the cell. As a testing 
mechanism, the luxP gene will be linked to a constitutive promoter on a cyanobacteria 
plasmid. The AI-2 response component ACC precursor cell will then be transformed 
with the luxP constitutive plasmid. Then, supernatant from the BLC_AI initially con-
structed and exposed to blue or UV-A light will be added to the ACC precursor cell to 
identify its ability to respond via bioluminescence. 
After verification that both the AI-2 and C-6-HSL response systems are viable in 
the respective ACC precursor cells. The linked DNA for the C-6-HSL response compo-
nent ACC precursor cell, luxP:phzE promoter and pzhR: constitutive promoter, will be 
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incorporated in the chromosomal DNA of the AI-2 response component ACC precursor 
cell, creating the final ACC cell. The ACC cell can then be exposed to C-6-HSL and AI-2 
to test its overall response. See Figures 14 to 17 for detailed construction diagrams. 
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Figure 14: Construction outline for a C-6-HSL responsive system for the ACC cell that will pro-
duce the luxP AI-2 receptor protein. 
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Figure 15: Construction outline for constitutive components required for con-
struction of the ACC cell. 
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Figure 16: Construction outline illustrating addition of AI-2 responsive elements 
and the luxR gene and promoter sequence to the ACC luxOUQ cyanobacteria cell, 
creating the ACC AI-2 response precursor cell ACC. 
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Figure 17: Construction outline illustrating addition of C-6-HSL responsive elements for 
luxP production for C-6-HSLACC precursor to the ACC AI-2 responsive precursor cell 
to create the final ACC cell. 
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Blue Light Converter Component Construction 
Experimental Plan 
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As a proof of concept demonstrating the physical potential to experimentally 
create the Bacteria-based Molecular Assay Detection [B-MAD] system that detects Clos-
tridium perfringens, construction began on the initial Blue Light Converter (BLC_AI) 
cell and its components. While cloning and construction of plasmid DNA was taking 
place, work was also underway on growing and sustaining cyanobacteria strain 6803, 
cyanobacteria 7942 and a reporter strain of V. harveyi for use in the development and 
experimentation of the B-MAD system. Overall, three main experimental tasks were un-
dertaken in this proof of concept work: cyanobacteria growth, V. harveyi growth and 
cloning of genes required to construct the Blue Light Converter (Al-2 version) cell. 
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Cyanobacteria Growth 
At about the same time, we received plates of two separate strains of cyanobacte-
ria, cyanobacteria synechocystis 6803 from Wim Vermaas at Arizona State University 
and cyanobacteria synechococcus elon-
gatus PCC 7942 from Lorraine van 
Waasbergen at the University of Texas at 
Arlington. Both strains of bacteria were 
grown in a BG-11 media recipe provided 
by Vermaas that was altered to allow for 
the use of commercial BG-11 broth (see 
Figure 18). In the liquid and agar cul-
tures of both cyanobacteria 6803 and 
7942, the final glucose concentration, 
BG-11 Li uid Media 1 L 
1636.7 mg BG-11 Broth (Fluka) 
38.9 mg Mg-504 {7 H20) 
1 ml Trace Minerals 
1636.7 mg 
38.9 mg 
1 ml 
10 ml 
3g 
15 g 
2.86 g 
1.81 g 
0.222 g 
0,39g 
0.079 g 
0.0494 g 
BG-11 r Plates 1L 
BG-11 Broth (Fluka) 
Mg-504 {7 H20) 
Trace Minerals 
1 M TES/NaOH buffer pH 8.2 
Na-tiosulfate (sclid) 
Difca B.act:a-agar 
Trace Mineral tL 
H3BO3 
MnCl2 ( 4 H20) 
ZnS04 {7 H20) 
Na2Mo04 (2 H2O) 
CuS04 ( 5 H2O) 
Co(NO3)2 (6 H2.O) 
when used, was SmM. While both cyano Table 1: Recipes for BG-11 agar and liquid media 
7942 and cyano 6803 auto-fluoresce red, 
each of the two strains are morphologically distinct. 
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Cultures of each strain were viewed under light and fluorescent microscopy. Cy-
anobacteria 7942 are visible 
under light microscopy 
without staining and appear 
as light green rods (see Fig-
ure 19). Cyanobacteria 7942 
fluoresce red as long bright 
rods (see Figure 20). During 
periods of rapid culture 
growth, when the culture 
tubes began to turn from a 
light green to a full, dark for-
est green color, cell division is 
apparent and visually looks 
similar to cellular filaments. 
Based on visual inspection of 
various different cultures 
with a variety of shades of 
green, the darker green the 
culture, the more dense the 
culture. 
-
g 
-
- I I 
-
I 
Figure 18: Image of cyanobacteria 7942 under light micros-
copy; lOOx. 
Figure 19: Image of cyanobacteria 7942 autofluorescence; 
lOOx. 
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Cyanobacteria 6803, on the other hand, appear as cashew-shaped doublets (see 
Figures 21 & 22). Only rarely is one 
found alone. Potentially cyanobac-
teria 6803 either exist as doublets or 
the doublets are the result of cell 
division. Most evidence, though, 
appears to support the theory that 
cyano 6803 exist as doublets. The 
cyano 6803 have, in general, a 
duller green color throughout the 
culturing processes, and the cul-
tures also change from a light 
green or clear at innoculation to a 
dark army green after growth. 
In our facility, cyanobacte-
ria were grown at ambient room 
temperature, typically around 23C, 
with anywhere between 2 & 4 de-
gree variations. Both cultures, but 
particularly the 6803 strain grew 
" 
Figure 20: Image of cyanobacteria 6803 doublets and 
their red autofluorescence; lO0x. 
-
,r 
0 
Figure 21: Image of cyanobacteria 6803 doublets using 
light microscopy; 40x. 
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slowly, taking as long as a week to reach a full dark green color when started from an-
other liquid culture. When starting from cells on a plate, growth may take as long as two 
weeks to become a visible green color. Liquid cultures were 50 ml in a 125 ml erlenmeyer 
flask, 100 ml in a 250 ml erlenmeyer flask or 200 ml in a 500 ml erlenmeyer flask. All 
growth was done under fluorescent lamps and shaking at roughly 225 rpm in a culture 
hood. Cultures grew equally well in all flasks. Using starter cultures, in 15 ml culture 
tubes, were less successful than starting cultures directly in 125 ml flasks, so starter cul-
tures were abandoned early on. An interesting feature of cyanobacteria identified during 
our experience growing them was their hardiness. Both strains of cyanobacteria are able 
to withstand extreme lengths of time without additional media or treatment of any kind. 
In fact, we have left 50 ml cultures in 125 ml erlenmeyer flasks stagnant for over 6 
months and have successfully started new cyanobacteria cultures of both strain 7942 and 
6803; these cultures grew and had identical morphology under light microscopy. 
The ability of cyanobacteria to survive long periods of time with few nutrients 
was a particularly useful characteristic during a major contamination of cyano supplies. 
We were even able to co-culture the two strains of cyanobacteria successfully (see Figure 
23). Due to difficulties in maintaining cyanobacteria 7942 and 6803 on plates and no abil-
ity yet to regrow frozen cul-
tures, the entire stock of cya-
nobacteria ended up con-
taminated with another mi-
crobe. 
Gram staining of the 
milky green cultures identi-
fied small gram-positive bac-
teria around the cyano bacte-
ria. The cyanobacteria 7942 
had a more morphologically 
distinct interaction with the 
gram-positive contaminants 
(see Figure 24). These uniden-
tified gram-positive spherical 
bacteria aggregate around the 
long cyanobacteria strain 7942 
rods, eventually leading to the 
death of the cyanobacteria. 
Images of cyanobacteria 6803, 
• 
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Figure 22: Image of cyanobacteria 7942 & 6803 co-culture; 
lO0x. 
r 
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Figure 23: Image of gram stained culture containing both 
cyanobacteria 6803 and the gram-positive contaminant; 
lO0x. 
• l 
• 
while not as definitive, did in-
dicate a similar mechanism of 
attack and overgrowth (See 
Figure 25). 
Starting new cultures in 
media without glucose proved 
advantageous for the cyanobac-
teria. After a few weeks away 
from glucose, the gram-positive 
spheres died off and only the 
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Figure 24: Image of gram stained culture containing both 
cyanobacteria 7942 and the gram-positive contaminant; 
lOOx. 
• 
cyanobacteria survived and continued to grow. Even though all cultures were contami-
nated initially, pure samples of both strains were successfully isolated through the star-
vation technique. This evidence for the rugged ability of cyanobacteria to survive harsh 
conditions for long periods of time lends credence to the notion that cyanobacteria are 
the best host for a modular B-MAD system, as it adds stability and another flexibility for 
application environments. 
70 
V. harveyi BB170 Reporter Strain Growth 
A reporter strain of V. harveyi, BB170, senses AI-2 and responds naturally to the 
signal with bioluminescence but lacks the machinery to produce the intercellular signal-
ing molecule [20]. The AI-2 reporter bug is an important assay tool for the construction 
of the Blue Light Converter and ACC cells. There is also the possibility that AI-2 from 
another, simpler to generate, source such as E.coli will be incorporated as an AI-2 gen-
erator for assay material to use during the development of the varying components to 
the B-MAD system. 
V. harveyi is a comma-shaped, gram-negative marine bacterium. It grows in AB 
Media. We obtained the recipe for AB Media from Bassler at Princeton (see Figure 26). 
When using the specified AB media, V. 
harveyi strain BB170 grows in cultures 
in 1 to 2 days at ambient room tempera-
tures. It was grown shaking at roughly 
225 rpm in erlenmeyer flasks. V. harveyi 
grew successfully in every configuration 
of culture size, from small starter cul-
11.'.S.l g1 
if.. : 'ii 
2J) 9 
900 ml 
i'hCI 
Mg~!'.Ml 
"" i.l-l to '1 . (I w/ KOO. i:11:: la v:e 
. fr.ee) 
illi ml NI ah:s.~.IDlil ? h_O"~h,_at . !PHI 1.0 
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2!li nn l · Oi:it; ii ··=a!il 
Table 2: AB Media recipe for culture of Vibrio 
harveyi. 
tures right through to 1 liter cultures. Even though V. harveyi strain BB170 lacks the abil-
ity to produce AI-2 or VAI and thus cannot bioluminesce, a dim glow can be observed 
from the larger cultures (1 
liter) in a darkroom with all 
of the lights off. This level of 
bioluminescence would 
then represent a baseline 
level to compare to re-
sponses to various experi-
mental systems where AI-2 
is produced. 
For verification and 
completeness, some V. har-
veyi were gram stained (see 
Figure27) and others were 
stained with BBi, a fluores-
cent stain (see Figure 28) . 
The stains provided clear 
evidence of the cell mor-
phology. The comma shape 
is apparent in the stains. 
The large cell densities that 
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Figure 25: Image of the comma-shaped, gram-stained Vibrio 
harveyi strain BB170; 40x. 
Figure 26: Image of V harveyi BB170 under fluorescence after 
BBi staining; 40x. Small bright spots are V harveyi BB170. 
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grow rapidly in the cultures is also evident, especially in the gram stain, which was 
taken from a culture less than a week old. An interesting observation of V. harveyi is 
their tendency to aggregate in the cultures, which is often still visible in the staining. In 
growing cultures, it was not uncommon to notice cloudy regions. These regions of the 
culture, when gently shaking the cultures in one's hand appear to look similar to a 
cotton-ball type consistency, with the entire culture being a milky white color. The media 
itself is completely clear, so it is easy to monitor growth of the bacteria. V. harveyi stran 
B8170 will prove and excellent assay tool because of its ease of growth and simply assay 
procedure for detection of Al-2. V. harveyi B8170 has successfully been frozen and 
stored. Testing has demonstrated that the bacteria can easily be re-cultured from frozen 
stock in starter culture tubes (15 ml) with a few ml of media. 
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Component Construction for AI-2 Blue Light Converter 
The AI-2 Blue Light Converter cell is the first step towards building the final 
BLC. In actuality, the only difference between the AI-2 Blue Light Converter and the final 
B-MAD Blue Light Converter is 
one gene. The steps to create 
the AI-2 Blue Light Converter 
are broken away from the steps 
required to create the final Blue 
Light Converter. The AI-2 BLC 
converter is, in reality, nothing 
more than a cyanobacteria 
strain 7942 transformed with a 
plasmid containing the hliA 
gene linked to the 1 uxS gene 
(see Figure 29), which codes for 
an enzyme used to produce AI-
2. The addition of the pBLC_AI 
■ Iii 
~ 1 PCR 
-
■ ■ 
~ 
1 PCR 
c:::::::JI 1 TA Cloning 1 TA Cloning 
~ ~ ~ ~ 
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_!( ... ~ 
LuxS 
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Figure 27: Illustration of construction outline for the AI-2 
Blue Light Converter. 
plasmid to cyanobacteria 7942 will create the AI-2 BLC. 
The first step in the construction of the BLC is to choose a host plasmid to build 
in the required genetic components. For the AI-2 BLC (and actually the final BLC too), 
74 
the pSpec plasmid from Vermaas at Arizona State University is the backbone (see ap-
pendix A for sequence). The pSpec plasmid contains two antibiotic resistance genes, 
ampicillin and spectinomycin. The pSpec plasmid also has a enough unique restriction 
enzyme sites to accomodate cloning multiple genes into the plasmid. The pSpec plasmid 
initially received from the Vermaas lab was transformed into chemically competant sub-
cloning efficiency DHS alpha cells and grown. This vector has been successfully used in 
transformation of cyanobacteria 6803. 
The promoter for the hliA gene was acquired from van Waasbergen at the Uni-
versity of Texas Arlington. To clone the hliA promoter, the sequence of the promoter and 
hliA gene were used to design sequencing primers for the phlip plasmid received from 
van Waasbergen, as the sequence for the entire phlip plasmid was unavailable. Since the 
only portion of the phlip plasmid, which contains the hliA promoter, that we were inter-
ested in was the hliA promoter region, we designed sequencing primers from the se-
quence of the plasmid. These primers allowed us to successfully confirm the sequence of 
the promoter region as well as give interesting insight into the plasmid. The gene at-
tached to the promoter on the provided plasmid was not, in fact, the hliA gene (see ap-
pendix A for 930 BP sequence successfully obtained from sequencing primers). As a re-
sult, sequencing primers designed based on the hliA gene sequence were unsuccessful. 
Confirming the sequence of the phlip plasmid made it possible to plan for sub-cloning 
the promoter into the pSpec plasmid. 
Evaluating the restriction map of pSpec generated on the New England Biolabs 
website Nebcutter 2,0 utility, one unique 
restriction enzyme site, Ndel, and one two-
cutter restriction enzyme site, BamHI, were 
chosen for the insertion site (see Figure 30). 
BamHI was chosen because it is a robust, 
common and easy restriction enzyme to 
work with. When cutting with the BamHI 
enzyme, which cuts at bp 2419 and bp 
pSpec Vector Map 
(as pertains to BLC_AI-2) 
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4193, the spectinomycin resistance gene is 
lost. However, both multi-cloning regions 
Figure 28: pSpec vector map with pertinent 
enzyme sites for the BLC_AI-2 
remain, as does the ampicillin resistance 
gene. The Ndel enzyme site is a few hundred base pairs early, at 2186 bp. Neither en-
zyme site occurs in the hliA promoter sequence being cloned out. 
As there are not convenient enzyme sites of any kind, not limited to the Ndel and 
BamHl chosen, at the beginning or end of the hliA promoter sequence, the desired re-
striction enzyme sites will be designed into the PCR primers. Additional spare base pairs 
are added to the end of the primer, on the opposite side from the hliA promoter se-
quence, to ensure enzyme stability. The PCR primer 
sequence can be found in Appendix B. The PCR 
setup (see Figures 31 & 33) was run with the inten-
tion of TA cloning using Invitrogen's TA cloning kit 
and the pCR2.1 coning vector. TA cloning is a 
mechanism used to clone PCR products directly into 
a vector (see Figure 32). PCR leaves extra adenine 
bases on the ends of the PCR products. The 
TA cloning vectors have thymidine overhangs. 
Dian 'D. PClt P ram 
1 !H d;ag. Par 15 mill. 
2 95 dag far 1:lG 
:3 !J7 diag far 0:SG 
4 7.2 diag far 1:lG 
!i MtimH to st.., 2 
I n d;ag fmr 0:!0 
7 7.2 dag fra !:OD 
19 !told at 4 dag 
Table 3: Description of PCR pro-
gram used for PCR prior to TA 
Cloning. 
AA jjjjjjjj jjjjjjjjAA 
PCR Product 
Ii I I I I I I TT TTIIIIIII 
These thymidine overhangs bind the adenine 
overhangs on the PCR product during liga-
tion, closing the vector. 
Vector pCR 2.1 
The PCR program for PCR for the TA 
cloning of the hliA promoter with a Ndel re-
striction enzyme site at the 5' end and a 
I j I j I I I j # j jj I I jj j I I j I j I I I lIIIIIIII 
Vector pCR 2.1 PCR Product 
Figure 29: Illustration of TA Cloning. 
76 
BamHI site at the 3' end of the DNA is titled Dion TA. The specific number of cycles re-
quired in the program was optimized through work conducted on earlier PCR of various 
DNA. 
Immediately after the PCR reaction fin-
ished, a portion of the sample was run out on a 
gel for confirmation prior to cloning. A 1kb DNA 
ladder was the reference for the gel. The PCR 
came out successful, with the roughly 500bp band 
visible in a DNA gel (see figure 34). However, 
there was a bright band at the bottom 
of the gel. This band corresponds to 
the overloading of primer in the reac-
tion mixture. Prior to adding the prim-
ers, the lOOuM stocks are diluted by 
10. In this case, the dilution was 
skipped, but the PCR worked OK; 
proceeding with the TA cloning would 
be fine. 
Three separate ligation reac-
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Table 4: Description of TA Cloning reac-
tion setup. 
tions were setup for the hliA-TA don-
ing experiment. In reaction number 
one, 1 ul of the PCR product is directly 
added to the ligation reaction. In reac-
Figure 30: Gel Image from hliA TA cloning PCR 
confirming successful PCR of the roughly S00bp 
hliA promoter; lO0bp ladder ran for size compari-
son. 
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tion number two, 1 ul of PCR product is diluted 1:100, so that 6.4ng of DNA, approxi-
mately 1:1 vector to insert ratio, is used. In the 3rd TA cloning reaction for hliA, 3 ul of 
the 1:100 diluted PCR product is added to the reaction, yielding a vector to insert ration 
of approximately 1:3. The TA cloning 
reactions run were the recommended 
lOul reaction protocol in the Invitro-
gen TA cloning kit. After transforma-
tion of the ligation reaction the follow-
ing day, colonies of E. coli were seen 
on all incubated plates. Plasmid 
preparation of the colonies grown in 
liquid media using a Qiagen miniprep 
kit from the hliA-TA cloning were 
successful and had high yields of 
DNA. Having successfully created the 
hliA-TA plasmid, with the Ndel and 
Figure 31: Gel image of enzyme efficiency test with 
a 1kb DNA ladder: lanes 1&4 are Ndel, lanes 2 &5 
are PstI and lanes 3&6 are BamHl . 
BamHI sites now artificially flanking the hliA promoter, is possible to begin construction 
of the plasmid pBhliA. 
Prior to digestion of phliA-TA for further use in cloning, a quick check of enzyme 
efficacy was run on the phliA-TA plasmid. As there is also a Pstl enzyme site on the pCR 
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2.1 cloning vector and the enzyme will be required in later experimentation with the vec-
tor, Pstl is included in the study with BamHl and Ndel. The clearly definied and clean 
bands seen in the resulting gel 
from the test enzyme digestion 
indicate, at least in single diges-
tion, standard 4 hour digestions, 
BamHI, Pstl and Ndel are all 
effective and work with the pCR 
2.1 vector without surprises (see 
Figure 35). 
Samples of pSpec grown 
in E.coli DHS alpha cells and 
samples of phliA-TA grown in E. 
coli OHS alpha were isolated 
using a Qiagen plasmid mini-
Figure 32: Gel image with Ndel & BamHl digested pSpec 
vector illustrating the two distinct bands formed from the 
digestion (lane 4); 1kb DNA reference ladder. 
prep kit for digestion and subsequent ligation. To create a pBhliA plasmid, the pSpec 
host vector must be digested using BamHI and Ndel to create a piece of linear DNA to 
accept the insert. Conversely, the hliA promoter needs to be digested out of the phliA-TA 
plasmid for insertion into the cut pSpec (see Figure 36). 20ul double digestion reactions 
with 1 ul of each restriction enzyme used with the associated buffer to cut 1 ug of plasmid 
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DNA. The digests ran for 4 hours. The pSpec digestion yields two (2) large linear seg-
ments of DNA. The smaller of the two is the insert between Ndel and the second BamHI 
(the first is in the middle and lost during digestion) is discarded. The larger of the inserts 
has both restriction enzyme ends, 
the other sections of the multi-
cloning region and the ampicillin 
resistance gene. The hliA diges-
tion came out streaked and varied 
(see Figure 37), while the pSpec 
digestions were clean, neat and 
identical. Further investigation 
implied that the difference be-
tween the two types of hliA-TA 
digests was a result of the efficacy 
of Ndel to cut. In the digestions 
that had a slightly larger size (a 
blip on the lOObp ladder run), the 
Figure 33: Gel image of three (3) hliA-TA Ndel & BamHl 
digestions; every 2 lanes are the same (1,2 are both from 
the same sample, 3,4 the same and 5.6 the same). 1kb 
DNA reference ladder. 
NdeI enzyme did not cut. Depending on the orientation of the insert in the TA cloning 
vector (PCR products insert randomly forwards or backwards into the TA cloning kits), 
an Ndel site sits close to a BamHI site on the pCR 2.1 cloning vector. Thus, since BamHI 
cuts well, the implication is that the Ndel was unsuccessful at cutting off the small piece 
left between BamHI and Ndel at 
the end of the hliA promoter in 
some instances. By selecting the 
smallest of the hliA-TA digested 
samples, the sample most likely 
contains successful NdeI-BamHI 
digested inserts (see Figure 39). 
After digestion of the 
samples and running the sam-
ples out on gels, the desired 
bands were carefully cut out of 
the gel and run through a Qia-
gen gel extraction kit. Prior to 
ligation, a tiny portion of these 
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Figure 34: Gel image of 3 hliA Ndel and BamHl diges-
tions from Fig. 35 after gel extraction cleanup and 1 Ndel 
and BamHl pSpec digestion (barely visible); 1kb DNA 
reference ladder in outermost lanes and lOObp ladder in 
inner lanes. 
extracted samples were run out on a gel to ensure the individual components for the 
ligation were clean and accurate, maximizing the chances for a successful ligation (see 
Figure 38). The difference in the hliA cuts is more clearly shown in the post-gel extrac-
tion gel, while the band for the cut pSpec is barely visible (see Figure 36). The brightness 
in the bands serves as a general indicator of the DNA content of the respective bands. In 
these samples, the insert is 
far more concentrated than 
the pSpec vector. 
The pBhliA ligation 
reaction is run in a similar 
setup to the TA-cloning liga-
tion (see Figure 39). Here, 
there are three lOul ligation 
reactions run for the pBhliA 
ligation. Each reaction con-
tains lul of T4 DNA ligase 
and 1 ul of ligation buffer 
provided with the T4 DNA 
ligase. In the first reaction, no 
insert is added to the reac-
tion. Instead, there is 3ul of 
l 
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Figure 35: Illustration and vector diagrams for construction of 
pBhliA. 
cut vector and plain water. This reaction is designed to indicate to serve as a negative 
indicator of the ligation reaction. If the vector is properly cut and clean, it will not ligate 
with itself because it does not have matching ends. However, if the ends happen to be 
identical, allowing the vector to ligate to itself, this first reaction will be a warning that 
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any colonies appearing in the other ligations may be incorrect. It can also serve as an ef-
fective percent indicator in the event that some of the vectors do ligate themselves to-
gether. In this case, the ratio of colonies from this reaction compared to the number of 
colonies in the other reactions indicate the general ratio of successful to unsuccessful 
ligated colonies on the plates. In the second ligation reaction, 3ul of the cut pSpec vector 
and 0.6ul of the cut vector are combined with the T4 DNA ligase, buffer and sterile water 
to make up the lOul reaction. These amounts are supposed to be roughly a 1:1 vector to 
insert ratio. The third reaction is designed to be a 1:3 vector to insert ratio and provide 
an additional chance for ligation, as sometimes if ligations do not work at a 1:1 vector 
ratio, they may work at a 1:3 vector to insert ratio. In this reaction, 3ul of cut pSpec was 
combined with l.8ul of the cut hliA promoter, T4 DNA ligase, buffer and sterile water to 
make up the lOul reaction. The ligation reactions were left overnight in a thermocycler 
set to 14 deg C. 
The ligation results were clear. After transforming max efficiency OHS alpha 
chemically competent cells from Invitrogen, the plates incubated overnight. One plate 
was inoculated with 200ul of the transformation solution. The second plate was inocu-
lated with any bacteria remaining on the wand used to spread the 200ul in the first plate, 
increasing the chances of isolated colonies in the event of large transformation success. 
The plates from the first reaction yielded, as expected, no colonies, meaning that the vec-
tor should not re-ligate to itself. The second ligation reaction, intended to be a 1:1 vector 
to insert ratio, yielded 2 visible colonies. The third reaction, designed to be approxi-
mately a 1:3 vector to insert ration, yielded 4 visible colonies. As anticipated, the third 
reaction, at a 1:3 vector to in-
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sert ratio, had the largest 
yield. All of these were 
plated out again and then 
grown in liquid media and 
hliA promoter match\ Miscellaneous Seq. 
the plasmid pBhliA was iso-
lated through a Qiagen plas-
mid miniprep kit. One sam-
ple was submitted to se-
quencing. 
The sequencing re-
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Figure 36: Sequence verified vector map for pBhliA. 
sults from the submitted sample of pBhliA shows successful ligation of the hliA pro-
moter and the pSpec vector. A detailed sequence, including color-coded regions of the 
DNA, can be found in Appenix A (see Figure 40 for a vector map). The sequence did not 
match exactly as expected. At the beginning of the sequence, there are some discrepan-
cies in the first 13bp. These differences can easily be explained by looking at the graphi-
cal view of the sequence results (see Appendix A, pBhliA sequence). The dispute in this 
region is between double and triple nucleotides, and since the peaks are rounded and 
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long instead of sharp, it is plausible and very likely that in fact the first 13bp sequenced 
do in fact match the actual hliA promoter sequence perfectly. The other difference is to-
wards the end of the promoter region. There is some additional DNA that at first did not 
match anything know at the end 
of the matching part of the hliA 
promoter and before the begin-
ning of the pSpec plasmid. Care-
ful inspection of this region 
shows that this DNA sequence is 
actually part of the pCR 2.1 TA 
cloning vector. Looking at the se-
quence of the pCR 2.1 vector, the 
35 base pair region of DNA is lo-
h liA promoter match\ 
~ % 
Q) 
phliA-TA Vector Map 
(clone used for pBhliA) 
Figure 37: Vector map of phliA-TA used to create pBhliA. 
cated between the native BamHI restriction enzyme site in the pCR 2.1 vector and the 
insertion site (see Figure 41). For this strand of DNA to at the end of the insert region, the 
insert must have been cloned into the TA cloning vector in reverse (see Figure 3x). Addi-
tionally, a short section of DNA at the end of the hliA promoter, including the PCR 
primer and the artificially added enzyme site, is missing. Instead, the DNA ends in the 
sequence of DNA from the TA cloning vector. This phenomenon of losing the reverse 
PCR primer and associated DNA during TA cloning and then ligation to pSpec with the 
addition of a strand of DNA from the pCR 2.1 vector remains unexplained. However, 
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given that only a small portion of the hliA promoter DNA is missing, albeit close to the 
ATG site, the constructed pBhliA should be an effective plasmid to use in the creation of 
the Blue Light Converter Cell for both AI-2 and C-6-HSL responses. 
The next task in creating the blue light converter plasmid for AI-2 signaling is the 
incorporation of the luxS gene into the pBhliA or pSpec plasmid. First, the luxS plasmid 
on an unidentified plasmid with no known sequence, pBB2438, obtained from Bonnie 
Bassler at Princeton University, needs to be TA-cloned from the unknown plasmid with 
appropriate restriction enzyme sites flanking the gene. 
Evaluating the restriction enzyme sites on the pSpec plasmid and considering the 
luxS sequence and the enzyme sites being removed by the cloning of the hliA promoter 
into the pSpec vector, Sall and Pstl, at locations 4205bp and 4215bp in the pSpec se-
quence, respectively, were chosen as the enzymes to use in the cloning of luxS into the 
pSpec and/ or pBhliA plasmid. As was the case 
with the hliA-TA cloning and associated PCR, the 
PCR primers are designed with the restriction en-
zyme sites artificially added to either end of the 
gene, in this case luxS, with a few additional base 
pairs added for stability. Dion-TA was once again 
Lu:a:S TA CIOllln hn 
11h: PCR buff:. 10 ■I 
2...5 mM dnq,s 10 ■I 
s.aI prim• 1 ul 
PstI pnner 1 ul 
Ta._ polymerase 1 ul 
luSdH 2 ul 
dH20 75 ■I 
Total rm YDL 100 ul 
Table 5: Description of TA cloning 
reaction for the luxS gene. 
the PCR program used for the 
PCR of luxS for TA cloning. The 
program parameters remained the 
same as used in the hliA-TA don-
ing. 
A sample from the PCR 
reaction was run out on a gel to 
determine whether or not the 
PCR reaction worked. The result-
ing gel showed successful PCR 
(see Figure 43). The bright band 
representing the cloned luxS gene 
with newly attached restriction 
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Figure 38: Gel image of the results of the luxS PCR for 
TA cloning; the band at roughly 525bp, size of the luxS 
gene, confirms the successful PCR. lOObp DNA reference 
ladder. 
enzyme sites was at the correct location jn the lOObp ladder. The samples were then im-
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mediately prepared for ligation in the lnvitrogen TA cloning kit with the pCR 2.1 cloning 
vector. 
For the TA cloning ligation 
reaction, the same setup was used 
that was used in the pBhliA and 
hliA-TA cloning reactions. Three 
samples were run in lOul reactions. 
The first sample, a had no insert 
and only vector. The second sam-
ple had a 1:1 vector to insert ratio, 
and the third reaction had a 1:3 
vector to insert ratio. The ligation 
and transformation were success-
ful, as the incubated plates for vec-
Figure 39: Gel image illustrating the double digestion of 
pluxS-TA plasmid (first sample DNA lane). The roughly 
525bp land corresponds to the luxS gene cloned into the 
vector. 1kb DNA reference ladder. 
tor and insert had colonies, while the plates for vector alone had no colonies. These 
colonies were then plated out and grown in liquid media. Plasmids were isolated using a 
Qiagen plasmid miniprep kit, with good yield of DNA from the plasmid isolation kit. 
The pluxS-TA plasmid resulting from the TA cloning was evaluated sequentially 
and through traditional molecular biology techniques. A double digestion of the pluxS-
TA plasmid Sall and Pstl, was done for confirmation (see Figure 44). The first column, 
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the only pluxS-TA sample run in the gel, had a gel band close to the 500bp band in the 
1kb ladder, indicating that likely 
luxS is present in the sample. The 
sample was then sent for sequence 
analysis. 
Sequence analysis of plas-
mid pluxS-TA showed definitively 
that luxS and its associated restric-
tion enzyme sites are successfully 
cloned into the pCR 2.1 cloning 
vector. See Appendix A for the 
pluxS-TA Vector Map 
(sequence verified) 
Figure 40: Sequence verified vector map of pluxS-TA. 
specific sequence (see Figure 45 for vector map). The luxS sequences matched the known 
luxS sequence at every base pair. Additionally, the primers sequenced portions of the 
pCR 2.1 vector, and the vector matched perfectly to the sequence surrounding the luxS 
gene. Now that the pluxS-TA sequence has been confirmed, it is possible to continue 
with development of the AI-2 Blue Light Converter Plasmid. 
At this stage, additional cloning is required to create the pBLC for AI-2 prior to 
the transformation of cyanobacteria and the first creation of the first Blue Light Con-
verter Cell. Specifically, the luxS gene must be digested out of the pCR 2.1 cloning plas-
mid and into the pBhliA or into the pSpec first and then have the hliA promoter cloned 
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in the resulting plasmid. Once the luxS gene and hliA promoter are linked in a plasmid 
and sequence verified, it will be possible to finish the first Blue Light Converter. While 
tedious, the experimental evidence indicates that a Blue Light Converter, and the B-
MAD system in general, is possible with additional molecular biology work. 
Appendix A: Sequences 
pSpec Sequence: 
Appendices 
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TCTTCCGCTICCTCGCTCACTGACTCGCTGCGCTCGGTCGTICGGCTGCGGCGAGCGGTAT 
CAGCTCACTCAAAGGCGGTAATACGGTIATCCACAGAATCAGGGGATAACGCAGGAAAG 
AACATGTGAGCAAAAGGCCAGCAAAAGGCCAGGAACCGTAAAAAGGCCGCGTIGCTGG 
CGTITTTCCATAGGCTCCGCCCCCCTGACGAGCATCACAAAAATCGACGCTCAAGTCAGA 
GGTGGCGAAACCCGACAGGACTATAAAGATACCAGGCGTTICCCCCTGGAAGCTCCCTCG 
TGCGCTCTCCTGTICCGACCCTGCCGCTIACCGGATACCTGTCCGCCTTICTCCCTTCGGGA 
AGCGTGGCGCTTICTCATAGCTCACGCTGTAGGTATCTCAGTICGGTGTAGGTCGTICGCTC 
CAAGCTGGGCTGTGTGCACGAACCCCCCGTTCAGCCCGACCGCTGCGCCTIATCCGGTAA 
CTATCGTCTIGAGTCCAACCCGGTAAGACACGACTIATCGCCACTGGCAGCAGCCACTGG 
TAACAGGATIAGCAGAGCGAGGTATGTAGGCGGTGCTACAGAGTTCTTGAAGTGGTGGCC 
TAACTACGGCTACACTAGAAGAACAGTATITGGTATCTGCGCTCTGCTGAAGCCAGTIACC 
TICGGAAAAAGAGTIGGTAGCTCTTGATCCGGCAAACAAACCACCGCTGGTAGCGGTGGT 
TITITTGTITGCAAGCAGCAGATIACGCGCAGAAAAAAAGGATCTCAAGAAGATCCTTIG 
ATCTTITCTACGGGGTCTGACGCTCAGTGGAACGAAAACTCACGTTAAGGGATITIGGTCA 
TGAGATIATCAAAAAGGATCTTCACCTAGATCCTITIAAATIAAAAATGAAGTTTIAAATC 
AATCTAAAGTATATATGAGTAAACTIGGTCTGACAGTIACCAATGCTIAATCAGTGAGGCA 
CCTATCTCAGCGATCTGTCTATTICGTICATCCATAGTIGCCTGACTCCCCGTCGTGTAGATA 
ACTACGATACGGGAGGGCTTACCATCTGGCCCCAGTGCTGCAATGATACCGCGAGACCCA 
92 
CGCTCACCGGCTCCAGATITATCAGCAATAAACCAGCCAGCCGGAAGGGCCGAGCGCAG 
AAGTGGTCCTGCAACTITATCCGCCTCCATCCAGTCTATTAATTGTTGCCGGGAAGCTAGA 
GTAAGTAGTTCGCCAGTTAATAGTITGCGCAACGTTGTTGCCATTGCTACAGGCATCGTGG 
TGTCACGCTCGTCGTTTGGTATGGCTTCATTCAGCTCCGGTTCCCAACGATCAAGGCGAGT 
TACATGATCCCCCATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGGTCCTCCGATCGTTGTC 
AGAAGTAAGTTGGCCGCAGTGTTATCACTCATGGTTATGGCAGCACTGCATAATTCTCTTA 
CTGTCATGCCATCCGTAAGATGCTTTTCTGTGACTGGTGAGTACTCAACCAAGTCATTCTG 
AGAATAGTGTATGCGGCGACCGAGTTGCTCTTGCCCGGCGTCAATACGGGATAATACCGC 
GCCACATAGCAGAACTITAAAAGTGCTCATCATTGGAAAACGTTCTTCGGGGCGAAAACT 
CTCAAGGATCTTACCGCTGTTGAGATCCAGTTCGATGTAACCCACTCGTGCACCCAACTGA 
TCTTCAGCATCTTTTACTITCACCAGCGTITCTGGGTGAGCAAAAACAGGAAGGCAAAAT 
GCCGCAAAAAAGGGAATAAGGGCGACACGGAAATGTTGAATACTCATACTCTTCCTTTIT 
CAATATTATTGAAGCATTTATCAGGGTTATTGTCTCATGAGCGGATACATATTTGAATGTATT 
TAGAAAAATAAACAAATAGGGGTTCCGCGCACATTTCCCCGAAAAGTGCCACCTGACGTC 
TAAGAAACCATTATTATCATGACATTAACCTATAAAAATAGGCGTATCACGAGGCCCTTTC 
GTCTCGCGCGTTTCGGTGATGACGGTGAAAACCTCTGACACATGCAGCTCCCGGAGACGG 
TCACAGCTTGTCTGTAAGCGGATGCCGGGAGCAGACAAGCCCGTCAGGGCGCGTCAGCG 
GGTGTTGGCGGGTGTCGGGGCTGGCTTAACTATGCGGCATCAGAGCAGATTGTACTGAGA 
GTGCACCATATGCGGTGTGAAATACCGCACAGATGCGTAAGGAGAAAATACCGCATCAGG 
CGCCATTCGCCATTCAGGCTGCGCAACTGTTGGGAAGGGCGATCGGTGCGGGCCTCTTCG 
CTATTACGCCAGCTGGCGAAAGGGGGATGTGCTGCAAGGCGATTAAGTTGGGTAACGCCA 
GGGTITTCCCAGTCACGACGTTGTAAAACGACGGCCAGTGAATTCGAGCTCGGTACCCGG 
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GGATCCGCATGCCCGTITCCATACAGAAGCTGGGCGAACAAACGATGCTCGCCTTCCAGA 
AAACCGAGGATGCGAACCACTTCATCCGGGGTCAGCACCACCGGCAAGCGCCGCGACG 
GCCGAGGTCTTCCGATCTCCTGAAGCCAGGGCAGATCCGTGCACAGCACCTTGCCGTAGA 
AGAACAGCAAGGCCGCCAATGCCTGACGATGCGTGGAGACCGAAACCTTGCGCTCGTTC 
GCCAGCCAGGACAGAAATGCCTCGACTTCGCTGCTGCCCAAGGTTGCCGGGTGACGCAC 
ACCGTGGAAACGGATGAAGGCACGAACCCAGTGGACATAAGCCTGTTCGGTTCGTAAGC 
TGTAATGCAAGTAGCGTATGCGCTCACGCAACTGGTCCAGAACCTTGACCGAACGCAGCG 
GTGGTAACGGCGCAGTGGCGGTTTTCATGGCTTGTTATGACTGTTTITTTGGGGTACAGTCT 
ATGCCTCGGGCATCCAAGCAGCAAGCGCGTTACGCCGTGGGTCGATGTITGATGTTATGGA 
GCAGCAACGATGTTACGCAGCAGGGCAGTCGCCCTAAAACAAAGTTAAACATCATGAGG 
GAAGCGGTGATCGCCGAAGTATCGACTCAACTATCAGAGGTAGTTGGCGTCATCGAGCGC 
CATCTCGAACCGACGTTGCTGGCCGTACATTTGTACGGCTCCGCAGTGGATGGCGGCCTG 
AAGCCACACAGTGATATTGATTTGCTGGTTACGGTGACCGTAAGGCTTGATGAAACAACG 
CGGCGAGCTTTGATCAACGACCTTTTGGAAACTTCGGCTTCCCCTGGAGAGAGCGAGATT 
CTCCGCGCTGTAGAAGTCACCATTGTTGTGCACGACGACATCATTCCGTGGCGTTATCCAG 
CTAAGCGCGAACTGCAATTTGGAGAATGGCAGCGCAATGACATTCTTGCAGGTATCTTCG 
AGCCAGCCACGATCGACATTGATCTGGCTATCTTGCTGACAAAAGCAAGAGAACATAGCG 
TTGCCTTGGTAGGTCCAGCGGCGGAGGAACTCTITGATCCGGTTCCTGAACAGGATCTATT 
TGAGGCGCTAAATGAAACCTTAACGCTATGGAACTCGCCGCCCGACTGGGCTGGCGATGA 
GCGAAATGTAGTGCTTACGTTGTCCCGCATTTGGTACAGCGCAGTAACCGGCAAAATCGC 
GCCGAAGGATGTCGCTGCCGACTGGGCAATGGAGCGCCTGCCGGCCCAGTATCAGCCCG 
TCATACTTGAAGCTAGACAGGCTTATCTTGGACAAGAAGAAGATCGCTTGGCCTCGCGCG 
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CAGATCAGTTGGAAGAATITGTCCACTACGTGAAAGGCGAGATCACCAAGGTAGTCGGC 
AAATAATGTCTAACAATTCGTTCAAGCCGACGCCGCTTCGCGGCGCGGCTTAACTCAAGC 
GTTAGATGCACTAAGCACATAATTGCTCACAGCCAAACTATCAGGTCAAGTCTGCTTTTAT 
TATTTITAAGCGTGCATAATAAGCCCTACACAAATTGGGAGATATATCATGAAAGGCTGGC 
TTTITCTTGTTATCGCAATAGTTGGCGAAGTAATCGCAACATCCGCATTAAAATCTAGCGAG 
GGCTITACTAAGCTGATCCGGTGGATGACCTTTTGAATGACCTTTAATAGATTATATTACTA 
ATTAATTGGGGACCCTAGAGGTCCCCTTTTITATTITAAAAATTTTITCACAAAACGGTTTA 
CAAGCATAAAGCTTGCTCAATCAATCACCGGATCCTCTAGAGTCGACCTGCAGGCATGCA 
AGCTTGGCGTAATCATGGTCATAGCTGTTTCCTGTGTGAAATTGTTATCCGCTCACAATTCC 
ACACAACATACGAGCCGGAAGCATAAAGTGTAAAGCCTGGGGTGCCTAATGAGTGAGCT 
AACTCACATTAATTGCGTTGCGCTCACTGCCCGCTITCCAGTCGGGAAACCTGTCGTGCCA 
GCTGCATTAATGAATCGGCCAACGCGCGGGGAGAGGCGGTITGCGTATTGGGCGC 
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phlip sequence from the forward sequencing primer (930 BP) 
GCAACTATIGCGCAGGATCGGCAGTGGATIGCCCTGGAGTIGAATATCTGGCTGGGAGAA 
GTIACGGGCCAAACTGCAGATCAGCTCGGGTCCCCGTAAGTCCCAACGCAGCTGGAAGA 
TACTGCCTGCATCCGCTIGGGTCAACGCGATCGCCGTATCCAGAAACAGGCTGAGGGCAG 
CATCCGTGCTGTGTAGAGCGATCAGGGATICCCGAAACTGAGTCAGTGGGTITICGGCGG 
GATIGAGAGGGAGCGTCATCGCAGGCATGAGGAAGGCGATCGCTGCGCTCAGTCGAGGA 
GGCGCAAGCAGTCGCAGCTTACCGCCAGCGGCGAGAAATCGCAGTAGGGATCAGGCTIA 
GGGACTGACTGGGCAGAAAAAGATIAAGAAAAACGTCACAGAACTITACGTTGTGTIAC 
ACTICAAACAGAACAACCAACCAAAAGGAATICATTATGCGTAGCGGACGGATCCCCGG 
GTACGGTCAGTCCCTTATGTIACGTCCTGTAGAAACCCCAACCCGTGAAATCAAAAAACT 
CGACGGCCTGTGGGCATICAGTCTGGATCGCGAAAACTGTGGAATIGATCAGCGTIGGTG 
GGAAAGCGCGTIACAAGAAAGCCGGGCAATIGCTGTGCCAGGCAGTTITAACGATCAGTI 
CGCCGATGCAGATATTCGTAATIATGCGGGCAACGTCTGGTATCAGCGCGAAGTCTITATA 
CCGAAAGGTTGGGCAGGCCAGCGTATCGTGCTGCGTTTCGATGCGGTCACTCATTACGGC 
AAAGTGTGGGTCAATAATCAGGAAGTGATGGAGCATCAGGGCGGCTATACGCCATITGAA 
GCCGATGTCACGCCGTATGTTATTGCCGGGAAAAGTGTACGTATCACCGTTIGTGTGAACA 
ACGAACTGAACTGGCAGACTATCCCGCCNGGGA 
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hliA promoter sequence ( confirmed via sequencing) 
GGGAACATICAGCACTICGCCAGTAGTCGCCACGTAGCCCGCCAAACTATIGCGCAGGAT 
CGGCAGTGGATIGCCCTGGAGTTGAATATCTGGCTGGGAGAAGTTACGGGCCAAACTGCA 
GATCAGCTCGGGTCCCCGTAAGTCCCAACGCAGCTGGAAGATACTGCCTGCATCCGCTIG 
GGTCAACGCGATCGCCGTATCCAGAAACAGGCTGAGGGCAGCATCCGTGCTGTGTAGAG 
CGATCAGGGATICCCGAAACTGAGTCAGTGGGTTTTCGGCGGGATTGAGAGGGAGCGTC 
ATCGCAGGCATGAGGAAGGCGATCGCTGCGCTCAGTCGAGGAGGCGCAAGCAGTCGCAG 
CTTACCGCCAGCGGCGAGAAATCGCAGTAGGGATCAGGCTTAGGGACTGACTGGGCAGA 
AAAAGATIAAGAAAAACGTCACAGAACTTTACGTTGTGTTACACTICAAACAGAACAAC 
CAACCAAAAGGAATTCATI 
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pBhliA sequence: 
The red portion of the vector matches the insert. The black portion at the beginning is close to the 
hliA promoter sequence, however the signal is unclear here from sequencing. The green portion 
matches the pSpec host vector. The black section in the middle reflects a portion of the pCR 2.1 
vector. The hliA promoter, had inserted backwards in the pCR 2.1, and that is the BamHl site 
used in the cut. 
GCACGTAGCCGCCAACTATTGCGCAGGATCGGCAGTGGATTGCCCTGGAGTTGAATATCTGGCT 
GGGAGAAGTTACGGGCCAAACTGCAGATCAGCTCGGGTCCCCGNTAAGTCCCAACGCAGCTG 
GAAGATACTGCCTGCATCCGCTTGGGTCAACGCGATCGCCGTATCCAGAAACAGGCTGAGGGC 
AGCATCCGTGCTGTGTAGAGCGATCAGGGATTCCCGAAACTGAGTCAGTGGGTTTTCGGCGGG 
ATTGAGAGGGAGCGTCATCGCAGGCATGAGGAAGGCGATCGCTGCGCTCAGTCGAGGAGGCG 
CAAGCAGTCGCAGCTTACCGCCAGCGGCGAGAGATCGCAGTAAGGATCAGGCTTAGGGACTGA 
CTGGGCAGAAAAAGATTAAGAAAAACGTCACAGAACTTTACGTTGTGTTACAAGCCGAATTCC 
AGCACACTGGCGGCCGTTACTAGTGGATCCTCTAGAGTCGACCTGCAGGCATGCAAGCTTGGC 
GTAATCATGGTCATAGCTGTTTCCTGTGTGAAATTGTTATCCGCTCACAATTCCACACAACATAC 
GAGCCGGAAGCATAAAGTGTAAAGCCTGGGGTGCCTAATGAGTGAGCTAACTCACATTAATTGC 
GTTGCGCTCACTGCCCGCTTTCCAGTCGGGAAACCTGTCGTGCCAGCTGCATTAATGAATCGGC 
CAACGCGCGGGGAGAGGCGGTTTGCGTATTGGGCGCTCTTCCGCTTCCTCGCTCACTGACTCGC 
TGCGCTCGGTCGTTCGGCTGCGGCGAGCGGTATCAGCTCACTCAAAGGCGGTAATACGGTTATC 
CACAGAATCAGGGGATAACGCAGGAAAGAACATGTGAGCAAAAGGCCAGCAAAAGGCCAGG 
AACCGTAAAAAGGCCGCGTTGCTGGCGTTTTTCCATAGGCTCCGCCCCCCTGACGAGCATCACA 
AAAATCGAC 
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pluxS-TA sequence: 
ATTGGGCCCTCTAGATGCATGCTCGAGCGGCCGCCAGTGTGATGGATATCTGCAGAATTCG 
GCTTTGTGACGTCTTAGTCGATGCGTAGCTCTCTCAGCATTGACTCTGGCAGTGCCAATTC 
ATCATTCTTATTCACCGCCACACCCACTTCTAGAATGTTCTTCGCGATTTGCTTCGCTTCATC 
CAGAGAGTGCATCGCTGCTGTACCACATTGGTATTCGTTCAACTCAGGGATCTTGTTTTGGT 
TTTCTACTTTTAGTACGTCTTCCATCGCGGCAATCCAAGCGTCAGCCACTTGCTGCTCTGAA 
GGCGTACCAATCAAGCTCATGTAGAAACCAGTACGGCACCCCATTGGTGAGATATCAATG 
ATCTCAACGCTATCACCATTTAGGTGATTACGCATAAAGCCTGCGTACAAATGCTCTAATGT 
ATGAATTCCTTTCTCAGAAAGGATGTCTTTGTTTGGAGCAGTGAAACGTAGGTCGAATACC 
GTGATGGTGTCTCCTTTTGGAGTTTGCATCGTTTTAGCCACACGAACCGCTGGTGCATTCAT 
ACGCGTGTGGTCTACGGTAAAGCTGTCTAATAAAGGCATGTCGACCGCAGCCGAATTCCA 
GCACACTGGCGGCCGTTACTAGTGGATCCGAGCTCGGTACCAAGCTTGGCGTAATCATGG 
TCATAGCTGTTTCCTGTGTGAAATTGTTATCCGCTCACAATTCCACACAACATACGAGCCG 
GAAGCATAAAGTGTAAAGCCTGGGGTGCCTAATGAGTGAGCTAACTCACATTAATTGCGT 
TGCGCTCACTGCC 
Appendix B: PCR Primers 
PHLIP _front_rev: 
PHLIP _front_for : 
PHLIP _MID _for: 
PHLIP-f-r: 
CGA TIT GGC CCG TAA CTI CT 
CAT TCA GCA CTI CGC CAG TA 
CCT CAA GTG GIT GIT GCT GA 
AGA TAT TCAACT CCA GGG CAA TC 
hliAprom3_for: TCT CAT ATG GGG AAC ATT CAG CAC TIC GCC AGT AG 
hliAprom2_rev: GCG CCT AGG AAT GAA TIC CTI TTG GTT GIT G 
luxS2_for: GCG GTC GAC ATG CCT TIA TIA GAC AGC TIT ACC 
luxS2_ reverse: TGT GAC GTC TIA GTC GAT GCG TAG CTC TCT CAG 
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